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ABSTRACT
MECHANISM OF ACTIVATION OF PHOTORECEPTOR PHOSPHODIESTERASE 
BY TRANSDUCIN AND BY LOW MOLECULAR WEIGHT PROTEINS
by
Angela W. Norton 
University of New Hampshire, May, 2002
Rod photoreceptor phosphodiesterase (PDE) is the central enzyme o f  visual 
transduction. PDE is a heterodimer (Pa(3) with two associated inhibitory y subunits, and 
is bound to the disk membrane by isoprenyl groups. Each catalytic subunit contains a 
catalytic site and a high-affinity cGMP binding site. In this research, two independent 
mechanisms o f PDE regulation are addressed. The first part examines transducin 
activation of PDE, focusing on the interactions between the y subunits and Pa(3. The 
second part examines the 17 kDa 5 protein believed to regulate bovine PDE. We found 
that transducin activation o f PDE induces heterogeneity at the active sites as well as the 
cGMP binding sites, and that there is a strong correlation between cGMP binding and y 
binding to PDE. The PDE activition induced by transducin is approximately half of the 
maximum rate o f PaP lacking bound y inhibitory subunits. This research supports a 
model in which transducin interacts with y bound to only one o f the catalytic subunits. 
The relationship between cGMP and y binding to PDE may play a role in light adaptation 
of rod photoreceptor cells.
x
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The 8 protein is hypothesized to regulate adaptation o f  rod photoreceptor cells by 
5 binding to the prenyl groups on PDE and releasing PDE from the disk membrane and 
thereby preventing activation by transducin. The frog homologue o f the bovine 17 kDa 5 
protein was identified in frog retina, but the amount of the 8 in rod cells was low (0.03 ±
0.01 mol 8 per mol PDE). This is consistent with frog PDE being >95% membrane- 
associated. Recombinant frog 8 bound to PDE and was able to release PDE from the 
membrane. The majority o f the 8 in frog ROS is soluble, and the remainder does not co- 
purify with PDE when extracted from the membranes. Immunocytochemical evidence 
indicates that 8 localizes to the cone cells. We hypothesize that 8 may serve to direct the 
intracellular membrane trafficking for various prenylated proteins.
xi




Importance of vision research
A complete understanding o f visual transduction is necessary to fight retinal 
diseases. Retinitis pigmentosa is the name given to a group of inherited retinopathies. 
Approximately 1 in 3500 people suffer from retinitis pigmentosa. The retina is the tissue 
at the back o f the eye that includes the rod and cone photoreceptor cells. Rod 
photoreceptor cells are distributed across the retina. Cone photoreceptor cells are mostly 
located in the central region o f the eye termed the macula. The majority o f people with 
retinitis pigmentosa suffer from degeneration o f their rod cells. This results in night- 
blindness as well as the loss o f peripheral vision. As the disease progresses, cone cells 
are also affected, often leading to complete blindness (Phelan and Bok, 2000). It has 
been difficult to determine the exact cause of retinitis pigmentosa since several different 
factors can lead to the same symptoms. However, recent studies suggest that it is a 
genetic disease, but that environmental factors can influence the rate o f progression of 
retinal degeneration.
Another common photoreceptor cell disease is macular degeneration. This is the 
degeneration of the macula, affecting mainly the cone cells. People suffering from 
macular degeneration gradually lose vision directly in front o f them and loss o f visual 
acuity occurs as the cone photoreceptors degenerate (Fong, 2000). For elderly
1
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Americans, age-related macular degeneration is the major cause o f non-treatable 
vision loss. The exact cause o f age-related macular degeneration is still unknown. Loss 
of vision completely alters a persons lifestyle, prohibiting activities many people take for 
granted. For the elderly, the risk o f losing independence and the inability to perform 
simple daily tasks is a severe concern. To combat the degeneration of photoreceptor cells 
seen in clinical studies, research must be done to understand the visual process. Once the 
mechanism o f visual transduction in a healthy system is elucidated, the diseased state can 
be compared to see what occurred to cause the degeneration. This will allow the 
development o f  drugs to treat the specific problem that led to the loss o f  sight.
2. Visual Transduction
Visual excitation
Vertebrate photoreceptor cells are highly specialized neurons developed for visual 
transduction. There are two different types o f photoreceptor cells: cones are for color 
detection and daylight vision, while rods are for vision in low levels o f light. Although 
rod and cone photoreceptor cells have different roles, the cells are similar in their basic 
cellular function. Both consist o f an inner segment containing the vegetative cellular 
machinery (nucleus, mitochondria, etc.) and an outer segment composed o f  an extensive 
membrane system. The large surface area o f the outer segment membranes is the site for 
the protein components for the initial steps in vision. Though cellular morphology o f 
rods and cones differs somewhat between the species, the central components of visual 
transduction are well conserved throughout the vertebrates. There are three main stages 
of the visual process: excitation, termination and adaptation.
2
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Much is known about the excitation process o f visual transduction, as it is the 
most well-studied o f the G-protein coupled receptor pathways. A photon o f light enters 
the cell and is absorbed by a chromophore located in the central region o f the 
transmembrane receptor, rhodopsin (Figure 1.1). Upon light absorption, the 
chromophore, 11-cis retinal, undergoes a conformational change to all-trans retinal. This 
activates the receptor and catalyzes the exchange o f GTP for GDP on the G-protein,
D ark  - ...... ► Light
Figure 1.1. Excitation pathway for vision. The initial components for visual 
transduction are bound to the disk membranes of the outer segment of the cell. Light 
photoactivates rhodopsin, catalyzing the exchange o f GTP for GDP on Ta. T a  
dissociates and binds to PDE, leading to a drop in cGMP concentration in the cell. The 
cGMP-gated channels close and calcium levels drop, sending the light signal to the brain.
GTP
3
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transducin. G-proteins are named for their high affinity interactions with guanine 
nucleotides and serve to transduce signals in many biochemical pathways. Transducin is 
composed o f an a , P, and y subunit, with the GTP binding site on the a  subunit 
(Arshavsky et al., 2002). The a-subunit o f transducin with bound GTP (Ta-GTP) 
dissociates from the transducin py subunits, then binds to and activates the effector 
enzyme, phosphodiesterase (PDE). PDE hydrolyzes guanosine 3’, 5’- 
monophosphate (cGMP) to guanosine 5’-monophosphate (GMP), causing the total 
concentration o f cGMP in the outer segment to drop. In response to the drop in cGMP, 
the cGMP bound to the cGMP-gated ion channels dissociates and the channels close 
(Mendez et al., 2001; Pugh, Jr. and Lamb, 2000).
The cGMP-gated ion channels allow for a steady influx o f Na+ and Ca2+ into the 
outer segment o f the photoreceptor cell. When photoreceptor cells are not exposed to 
light, there is a circulating current with Na+ and Ca2+ entering the outer segment o f the 
cell through the cGMP-gated channel and exiting from the inner segment via a Na+/K+ - 
ATPase pump. When the cGMP-gated channel closes due to fight exposure, Ca2+, Na+, 
and small amounts o f  Mg2+ are no longer able to enter the cell, but Ca2+ is still pumped 
out o f the cell by the exchanger (Pugh, Jr. and Lamb, 2000). The decrease o f positive ion 
influx into the cell causes the membrane potential to become more negative. This causes 
the cell to become hyperpolarized, transmitting the signal o f  fight exposure to the 
synaptic terminal o f the photoreceptor cell which communicates to many other classes of 
retinal neurons before passing to the optic nerve.
Rod photoreceptor cells are capable o f detecting a single photon o f fight. This 
ability arises by two amplification steps that are intrinsically built into the visual
4
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transduction pathway. The first amplification step occurs upon activation o f rhodopsin. 
Once activated, rhodopsin catalyzes the activation o f transducin and the G-protein is 
released, but rhodopsin remains active. Thus, a single activated rhodopsin can continue 
to activate —100 transducin molecules until rhodopsin itself becomes deactivated. The 
second amplification step is the activation o f PDE. A single Ta-GTP binds to PDE, 
allowing the hydrolysis o f as many cGMP molecules as the enzyme encounters before T a 
is deactivated and dissociates (Pugh, Jr. and Lamb, 2000; Mendez et al., 2001; Arshavsky 
et al., 2002). The amplification o f the signal at these two steps allows for a very small 
stimulus to be reliably amplified and converted into a detectable signal to the nervous 
system.
Termination o f the visual pathway
As with many specialized pathways, termination o f the activated signal o f visual 
transduction is not merely the reverse of the activation mechanism. To turn off visual 
excitation, each o f  the two amplification steps must be separately blocked. The 
mechanism of deactivation o f rhodopsin is very well known (Figure 1.2). The decrease 
in intracellular calcium levels upon light activation stimulates a  Ca2+ feedback 
mechanism. Recoverin, a neuron-specific Ca2+-binding protein with two bound Ca2+, 
exists associated to rhodopsin kinase bound in the dark state. Light exposure greatly 
decreases the Ca2+ concentration, and the two Ca2+ bound to recoverin dissociate and 
release rhodopsin kinase from recoverin. Rhodopsin kinase is then available to 
phosphorylate distinct serine residues on rhodopsin. Phosphorylation o f rhodopsin 
produces a binding site for arrestin, a 48 kDa protein that physically blocks the G-protein
5
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activation site on rhodopsin to ensure transducin can no longer be activated (Pugh, Jr. and 
Lamb, 2000).
Figure 1.2. Deactivation o f rhodopsin. The decrease in calcium levels induced by light 
exposure releases rhodopsin kinase from its association with recoverin. Rhodopsin 
kinase then phosphorylates distinct residues on the C-terminus o f rhodopsin. Once the 
phosphorylation has taken place, arrestin will bind to rhodopsin, blocking the binding site 
o f transducin and prohibiting further activation of the pathway.
After rhodopsin is deactivated, the chromophore dissociates from its ligand binding site 
on the rhodopsin receptor and is reduced to all-trans retinol. In this state, the pigment 
binds to an interphotoreceptor matrix retinoid binding protein (IRBP) which transports it 
to the retinal pigment epithelium. It can then be converted to 11-cis retinal and returned 
to the outer segment o f the photoreceptors bound to IRBP to complete the cycle of 
pigment regeneration.
PDE activity must also be inhibited for termination o f the visual response. PDE 
remains activated until hydrolysis o f GTP to GDP on T a  occurs, allowing Ta-GDP to 
dissociate and rebind to T(3y. Recently it has been shown that GTPase activating proteins 
(GAP) work together to regulate the kinetics o f transducin deactivation. To enhance 
hydrolysis o f GTP, Regulator o f G-protein Signaling 9 (RGS9) exists in a complex with 
type 5 G-protein P subunit (GP5L) and increases the intrinsic GTPase activity of
Light
6
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transducin (He et al., 1998). GAP proteins work by stabilizing the transition state o f the 
G-protein (in this case T a) to favor GTP hydrolysis (Arshavsky et al., 2002).
Deactivation of T a allows for the y subunit to return to its tight association with PDE, 
blocking the catalytic site o f  the enzyme. In vitro studies have shown that y released 
from Pa(3 further enhances the GTPase activity o f transducin with RGS9 and G05L 
(Arshavsky and Bownds, 1992; He et al., 1998; Makino et al., 1999).
The final step to recovering the dark-adapted state o f the cell is the production of 
cGMP. cGMP is formed by photoreceptor guanylate cyclase. In the dark, guanylate 
cyclase binds guanylate cyclase activating proteins (GCAPS). These are calcium binding 
proteins, that dissociate from guanylate cyclase when light activation decreases the Ca2+ 
in the cell. The release o f  the GCAPS from guanylate cyclase stimulates the production 
o f cGMP, leading to recovery o f  the membrane potential.
Photoreceptor cell adaptation
The final stage o f the visual process is adaptation. Adaptation is the term used to 
describe how photoreceptor cells adjust their photoresponse based on the previous history 
o f light exposure. When photoreceptor cells have been in the dark long enough for the 
transduction pathway to be completely turned off and the dark current restored, the dark- 
adapted state is reached. There are two types o f light adaptation, background adaptation 
and bleaching adaptation. The photoreceptor cells must be able to recognize a change in 
light intensity when a background light exists, this is called light (or background) 
adaptation. Part of the adaptation mechanism is achieved by the two different types of 
photoreceptor cells. Rod photoreceptor cells are for the detection o f  very low levels of
7
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light, down to a single photon. During the daytime, rod cells are completely saturated 
with light. Bleaching adaptation is a continuous activation o f the pathway that is 
believed to be due to the presence of bleached pigment.
Background adaptation is composed o f two phases; a rapid phase lasting only a 
few seconds, and a slow phase that occurs after tens of seconds of light exposure. The 
rapid phase o f light adaptation is stimulated by the low Ca2+ levels in the outer segment 
arising from the closure of the cGMP-gated ion channels. This decrease in the Ca2+ 
levels stimulates guanylate cyclase-activating proteins, causing guanylate cyclase to 
produce cGMP which combats the drop in cGMP concentration due to PDE catalytic 
activity. Simultaneously, the low Ca2+ levels increase the affinity of cGMP for the 
cGMP-gated ion channels permitting them to open at lower cGMP concentrations. While 
the rapid phase o f  light adaptation occurs at all light intensities, the slow phase is 
observed only when the light intensity suppresses greater than 50% of the dark current. 
The actual cause o f the slow phase o f background adaptation is unknown, and the 
continued drop in Ca could mean that this effect is also mediated by the overall Ca m 
the outer segment o f the photoreceptor cell, but not necessarily (Calvert et al., 2002; 
Bums and Baylor, 2001).
Bleaching adaptation is the ability of the rod photoreceptor cells to adjust to 
daytime saturation and recover for night vision. Rod photoreceptor cells exposed to 
bright light become desensitized, preventing them from further stimulation by light. It is 
well known that in order to recover from a bright flash of light, the cell must regenerate 
the visual pigment. However, throughout the time of the pigment regeneration, the cell 
behaves as though it is being continuously exposed to light, as the PDE remains active
8
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and cGMP levels are low. The cause o f this decrease in sensitivity is now believed to be 
due to the presence o f bleached pigment in the cell. Rhodopsin is a protein containing a 
covalently bound chromophore, 11-cis-retinal. Dining the visual cycle o f pigment 
regeneration, the light-activated all-trans-retinol must dissociate and be exported to the 
retinal pigment epithelium. Recent work suggests that the free opsin molecule (bleached 
pigment) is able to directly activate transducin, causing desensitization by maintaining 
the activated pathway (Melia, Jr. et al., 1997). The recovery o f  the sensitivity o f the 
pathway occurs with the regeneration of the 11 -cis-retinal, allowing dark adaptation, and 
the pathway is terminated until the next flash o f light (Fain et al., 2001).
3. Structure and Regulation of Photoreceptor Phosphodiesterase 
Structure and Function of PDE
Due to its central role in the visual transduction pathway, PDE has been a major 
focus o f research. There are eleven different members o f  the PDE superfamily that have 
been discovered thus far. All members of the PDE superfamily share sequence similarity 
in the region corresponding to the active site o f the enzyme (SMART domain ID: HDc). 
The photoreceptor cell PDEs (both rod and cone) discussed here are designated as PDE6. 
Rod PDE is a heterodimeric protein composed o f a  and p catalytic subunits (PaP). The 
catalytic subunits are tightly associated with inhibitory y  subunits (Figure 1.3). PDE6
9
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Figure 1.3. S tructure of rod  photoreceptor PDE. PDE is composed o f  two catalytic 
subunits, PaP; and two identical inhibitory subunits, y. P a  and Pp each contain a 
catalytic site for cGMP hydrolysis, as well as an N-terminal GAF domain that binds 
cGMP. PDE is attached to the membrane with isoprenyl groups. In mammalian ROS, 
30% of the PDE exists in a soluble form bound with a bound 8 subunit.
subunits contain a C-terminal catalytic domain as well as a tandem pair o f  N-terminal 
GAF domains encoding for cGMP binding sites (Artemyev et al., 1998). PDE2, PDE5, 
PDE 10 and PDE11 are members o f  the PDE superfamily that also contain GAF domains. 
PDE2 demonstrates cooperative behavior, such that cGMP binding at the noncatalytic 
sites stimulates cGMP hydrolysis at the catalytic site. Alternately, PDE5 shows allosteric 
regulation, where the cGMP binding sites control the accessibility o f  a phosphorylation 
site responsible for regulating the catalytic site (Martins et al., 1982; Yamamoto et al., 
1983; Corbin et al., 2000). The exact role o f the GAF domains on PDE10 and PDE11 are 
not well known.
Due to its importance in vision, research has focused largely on understanding 
how PDE6 is regulated. One mechanism of direct regulation that could occur is 
cooperation between the active sites and the noncatalytic cGMP binding sites as seen in
10
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PDE2. However, up to this point no evidence has been found to show any direct control 
o f photoreceptor PDE activity from cGMP binding to the noncatalytic sites (Arshavsky et 
al., 1992; Mou and Cote, 2001).
The C-terminal region of each of the catalytic subunits contains the consensus 
sequence (CaaX) for post translational modification by protein prenyltransferases. The a -  
subunit is famesylated and the (3 subunit is geranylgeranylated on the cysteine residue o f 
the consensus sequence. Exposure o f PDE6 to limited trypsin proteolysis cleaves off a 
portion of the C-terminus o f the catalytic subunits, releasing them from their membrane- 
associated state. This suggests that prenylation o f the catalytic dimer is necessary for 
membrane binding (Ong et al., 1989; Catty and Deterre, 1991), a mechanism that is often 
used in signal transduction pathways. In vision, the coupling o f PDE6 to the membrane 
ensures that the PDE is localized near transducin and can be quickly activated by light 
exposure. In mammalian ROS up to 30% of the PDE is soluble with a bound 5 protein 
(Gillespie et al., 1989). It is believed that 5 may play a role in adaptation by uncoupling 
PDE from transducin activation (see below).
In a dark-adapted photoreceptor cell, PDE6 exists with two tightly associated y 
subunits (Cote, 2000). y binds to the catalytic dimer with very high affinity (Kd<10 pM) 
(Wensel and Stryer, 1986) and inhibits cGMP hydrolysis by physically blocking the 
active site (Takemoto et al., 1993; Artemyev et al., 1998). The high affinity interaction 
ofy is through the central region of the protein (residues 24-45) whereas the C-terminal 
region of the protein inhibits cGMP hydrolysis (Mou and Cote, 2001).
There are many fewer cone cells than rod cells in the majority o f  vertebrate 
retinas. Thus, less is known about cone PDE because it is difficult to obtain purified
11
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biochemical amounts o f the enzyme to study. Sequence analysis shows that cone PDE 
exists as a homodimer o f a ’ subunits. Each o f  these catalytic subunits contains an active 
site for cGMP hydrolysis and at least one noncatalytic cGMP binding site. Similar to rod 
PDE, the catalytic activity of cone PDE is regulated by the binding o f two inhibitory y’ 
subunits. There is still a lot o f work that needs to be done to characterize cone PDE and 
understand how it is regulated in vivo.
v release from PaB upon transducin activation
There is some debate as to the interactions o f the PDE subunits upon transducin 
activation o f PDE. In bovine PDE, y has such a high affinity for one o f the catalytic 
subunits that cGMP is not readily exchanged from one o f the noncatalytic binding sites. 
However, frog PDE contains two exchangeable cGMP binding sites at all times. It is 
well known that there is a highly cooperative relationship between occupation o f the 
cGMP binding sites and y binding affinity. Experimental manipulations can remove most 
y from its association with Pap when PDE is activated by Ta-GTP in the absence of 
cGMP. It remains to be seen whether cGMP levels in the outer segment drop low enough 
to allow y to be released from Pap during the visual process. The specifics o f  y release 
from Pap  occurring in vivo are further examined in this thesis. If  y is released in vivo, it 
could serve an important function, since free y binds to RGS9 to stimulate GTP 
hydrolysis on transducin, thereby causing Ta-G D P to dissociate from y leading to 
termination o f visual transduction (Arshavsky and Bownds, 1992; Calvert et al., 1998; 
Makino et al., 1999). Thus, one could envision the dissociation o f  y being involved in
12
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light or bleaching adaptation, by reducing cGMP hydrolysis and thus reducing 
expenditure o f metabolic energy.
Regulation of PDE6 by phosphorylation
One line o f current research is looking at whether phosphorylation o f the y subunit 
of PDE serves to regulate PDE. When y is free from association with Pap, it can also 
serve as a substrate for phosphorylation in vitro. Previous research suggested that when y 
is phosphorylated, it inhibits PDE catalysis stronger than the unphosphorylated form (Xu 
et al., 1998; Tsuboi et al., 1994; Hayashi et al., 2000; Udovichenko et al., 1994).
However, more recent results contradict this finding. Instead, they propose that once 
phosphorylation o f y occurs, it is no longer capable o f  binding to Ta-GTP. Thus, the 
phosphorylated y will reassociate with P ap  without binding to any alternative Ta-GTP 
molecules that may be present, thus speeding up the recovery phase o f the pathway 
(Paglia et al., 2002). This would be important, as the stoichiometry o f T a to PDE is 12 to 
one, respectively in ROS (Arshavsky et al., 2002). Another hypothesis is that 
phosphorylation o f y actually serves to regulate an alternate pathway located in the rod 
outer segment. If  y does indeed get released from PDE due a large decrease in the cGMP 
concentration, it would then make an excellent substrate for phosphorylation. Since this 
soluble, phosphorylated y cannot bind to T a, it would be available for interacting with 
proteins from another signal transduction pathway. However, at this point it is still 
unclear as to whether or not significant levels o f y phosphorylation occur in vivo.
The phosphorylation o f PaP is also being examined as a mechanism o f enzyme 
regulation, but the importance of this has not yet been completed. PDE5 has been shown
13
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to be regulated by phosphorylation o f its catalytic subunits such that when cGMP is 
bound to the noncatalytic sites, PDE5 is more likely to be phosphorylated (Corbin et al., 
2000). The likelihood o f PDE6 being phosphorylated in vivo and the effect of this 
phosphorylation are currently being examined.
A 17 kDa 8 protein is a putative subunit of PDE6
PDE is likely to be regulated by other proteins located in the outer segment. In 
bovine ROS, a 17 kDa 5 subunit solubilizes PDE from the membrane such that -30%  of 
bovine rod PDE exists off in the cytosol (Gillespie et al., 1989; Florio et al., 1996). This 
5 protein is conserved among mammals showing a 96% sequence identity. Similar 
proteins have also been found in amphibians (80% identity) as well as C. elegans (70% 
identity) and D. melanogaster (60% identity) (Florio et al., 1996; Li and Baehr, 1998; Li 
et al., 1998; Lorenz et al., 1998; Adams et al., 2000). The proposed role of 5 is to 
regulate PDE by removing it from the rod disk membranes and away from membrane- 




Figure 1.4. Proposed role o f the 8 protein. Upon light exposure, Ta-GTP 
dissociates from T(3y, and binds to PDE causing activation. When light activation is 
prolonged, 8 binds to PDE at the C-terminus and releases it from the membrane, leaving 
Ta-GTP bound by its myristoyl group to the disk membrane.
14
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The interaction between PDE and 8 is believed to occur at the C-terminus o f the 
catalytic subunits, and to involve the isoprenyl groups which attach PDE to the 
membrane. Trypsinized PDE, lacking the C-terminus o f  the catalytic subunits, does not 
bind to 5. In addition, release o f PDE from the disk membranes can be blocked by 
peptides containing a small sequence from the PDE C-terminus. PDE solubilized by 5 
contains a higher level o f carboxymethylation than the PDE that remains membrane- 
bound (Cook et al., 2000).
Besides altering membrane association, 8 also regulates PDE by altering cGMP 
binding to the noncatalytic sites (Mou et al., 1999). In bovine PDE, the interaction o f the 
y subunit with one o f the catalytic subunits is so tight that the cGMP is not released. 
Addition o f 8 to this membrane-associated PDE both releases the enzyme from the 
membrane and allows cGMP to be exchanged from both o f the noncatalytic cGMP 
binding sites. However, it is still unclear whether 8 plays a role in regulating PDE in 
vivo.
Regulation of PDE by GAKP
Another protein believed to interact with PDE and decrease its catalytic activity is 
GARP (glutamic acid-rich protein). Research suggests that GARP serves to prevent 
cGMP hydrolysis when rod photoreceptor cells are completely saturated with light 
(Korschen et al., 1999). GARP binds to PDE, and is hypothesized to compete with T a- 
GTP thereby reversing transducin activation o f PDE. The interaction o f PDE with other 
photoreceptor proteins is currently being examined. It is possible that there exists a
15
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signaling complex for proteins involved in visual transduction, similar to the inad 
complex found in Drosophila. As there are many proteins in the outer segment o f  rod 
photoreceptor cells, it is likely that some proteins regulating visual transduction have not 
yet been discovered.
4. Thesis research goals
Model for vision research
Due to the conservation o f rod photoreceptor proteins in the visual pathway, the 
species used for research does not often matter. Most o f the work done to date used 
bovine photoreceptor cells because they are available in large quantities from 
slaughterhouses. The concern arises in that bovine retinas obtained from the 
slaughterhouses are light-adapted, and the conditions o f retinal isolation are not under the 
control o f the investigator. Thus, in order to make a more physiological assessment of 
the visual transduction pathway, the common bullfrog (Rana catesbeiana), is often used. 
The animals are easy to maintain in a controlled light environment, and all aspects of 
retinal isolation and light exposure can be controlled. In this way, preparations o f dark- 
adapted purified ROS can be isolated and used to compare the biochemical pathways of 
the rod outer segment to the well characterized electrical responses o f the same cell 
preparation.
Goal of thesis research
This research focuses on the regulation of rod PDE through cGMP, Py, T a  or 5 
binding. The first section of the thesis examines a complete characterization o f frog
16
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PDE, observing catalytic rates as well as cGMP association, dissociation and equilibrium 
binding to the noncatalytic sites. The correlation between cGMP binding to the 
noncatalytic sites and y binding to PDE was studied in more detail as well. Each of these 
pieces combined to form a model describing transducin activation of PDE in 
physiologically competent frog ROS. The second section o f the thesis deals with the 
regulation o f PDE by the 5 protein in frog ROS. The in vivo levels of the 5 protein in 
frog ROS was measured under several illumination conditions. For comparison to 
previous studies in bovine ROS, the in vitro effect o f frog 5 on PDE was also measured. 
Co-purification o f 6 and PDE was examined to test the possibility that delta or delta-like 
proteins interact with PDE to regulate visual transduction. The final part o f  this thesis 
contains research that addresses PDE-binding proteins. Much o f this section focuses on 
the y subunit o f PDE, but the existence of other PDE-binding proteins is also explored. 
These experiments were preliminary studies that evolved into projects studied by myself 
or other lab members. Some o f these observations may be used for future research in the 
lab.
17
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CHAPTER 2
MECHANISM OF TRANSDUCIN ACTIVATION OF FROG ROD 
PHOTORECEPTOR PHOSPHODIESTERASE: ALLOSTERIC 
INTERACTIONS BETWEEN THE INHIBITORY y SUBUNIT AND 
THE NONCATALYTIC cGMP BINDING SITES1
Summary
The rod photoreceptor phosphodiesterase (PDE)2 is unique among all known 
vertebrate PDE families for several reasons: it is a catalytic heterodimer (aP), it is 
directly activated by a G-protein, transducin, and its active sites are regulated by 
inhibitory y subunits. Rod PDE binds cGMP at two noncatalytic sites on the aP  dimer but 
their function is unclear. We show that transducin activation o f frog rod PDE introduces 
functional heterogeneity to both the noncatalytic and catalytic sites. Upon PDE
1 This paper was published in the Journal o f Biological Chemistry: Norton, A. W., 
D'Amours, M. R., Grazio, H. J., Hebert, T. L., and Cote, R. H. (2000) J.Biol.Chem. 275, 
38611-38619. This work was supported by National Institute o f Health Grant EY-05798 
(to R. H. C.). This paper is scientific contribution 2058 from the New Hampshire 
Agricultural Experiment Station.
2 The abbreviations used are: PDE, phosphodiesterase (EC 3.1.4.35); PDE6, retinal 
photoreceptor PDE; PaP , catalytic heterodimer of PDE; Py, inhibitory 10 kDa y subunit 
o f rod PDE; a t, a-subunit o f the rod photoreceptor G-protein, transducin; ROS, rod outer 
segments; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; 
nPDE, nonactivated PDE; tPDE, trypsin-activated PDE; taPDE, transducin-activated 
PDE; GTPyS, guanosine 5’-0-[3-thiotriphosphate], a t-GTPyS, activated form o f a t; kat, 
turnover number for activated PDE (units: cGMP hydrolyzed per s) based on the PaP 
dimer concentration; PDE1, calcium-calmodulin-dependent PDE.
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activation, one noncatalytic site is converted from a high affinity to low affinity state, 
while the second binding site undergoes modest decreases in binding affinity. Addition o f 
y to transducin-activated PDE can restore high affinity binding as well as reducing cGMP 
exchange kinetics at both sites. A strong correlation exists between cGMP binding and y 
binding to activated PDE: dissociation of bound cGMP accompanies y dissociation from 
PDE, while addition o f either cGMP or y to a p  dimers can restore high affinity binding 
o f the other molecule. At the active site, transducin can activate PDE to about one-half 
the turnover number for catalytic a p  dimers completely lacking bound y subunit. These 
results suggest a mechanism in which transducin interacts primarily with one PDE 
catalytic subunit, releasing its full catalytic activity as well as inducing rapid cGMP 
dissociation from one noncatalytic site. The state o f occupancy o f the noncatalytic sites 
on PDE determines whether y remains bound to activated PDE or dissociates from the 
holoenzyme, and may be relevant to light adaptation in photoreceptor cells.
Introduction
Initiation o f the phototransduction cascade in vertebrate rod photoreceptors by 
light results in the sequential activation o f the visual pigment (rhodopsin), the 
photoreceptor G-protein (transducin), and the effector enzyme (cGMP phosphodiesterase, 
PDE)[for reviews, see ref. (Stryer, 1991; Pugh, Jr. and Lamb, 1993; Helmreich and 
Hofmann, 1996; Arshavsky and Pugh, Jr., 1998)]. The PDE present in rod and cone 
photoreceptors (classified as PDE6) differs in several ways from other classes o f  
mammalian phosphodiesterases (Loughney et al., 1996; Manganiello and Degerman,
1999; Soderling and Beavo, 2000): rod photoreceptor PDE forms a catalytic dimer from
19
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two closely related a  and p subunits (PaP); rod and cone PDE are directly regulated via 
heterotrimeric G-proteins; the catalytic constant (kcat) for rod PDE is ~1000-fold greater 
than for any other class o f PDE; the catalytic activity of photoreceptor PDE is potently 
inhibited by binding o f an inhibitory y subunit (Py) [for reviews, see ref. (Takemoto et al., 
1993; Artemyev et al., 1998)].
Transducin activation o f PDE results from binding of the activated transducin a t 
subunit (a r GTP) to one or more sites on the PDE holoenzyme. One result o f this 
interaction is the displacement o f  the inhibitory Py subunit from its binding site in the 
catalytic pocket o f PDE. It is not clear, however, whether each PDE catalytic subunit 
binds Py with equal affinity, whether a t-GTP can activate each catalytic site equally well, 
and under what conditions the a t-GTP-Py complex dissociates from PaP- Conflicting 
results reported by different laboratories may reflect underlying differences in how the 
phototransduction components were isolated and studied, as well as species differences in 
the protein-protein interactions o f transducin and PDE (Yamazaki et al., 1983; Wensel 
and Stryer, 1986; Bennett and Clerc, 1989; Bennett et al., 1989; Whalen and Bitensky, 
1989; Yamazaki et al., 1990; Wensel and Stryer, 1990; Clerc and Bennett, 1992; Clerc et 
al., 1992; Otto-Bruc et al., 1993; Bruckert et al., 1994; Dumke et al., 1994; D’Amours and 
Cote, 1999; Berger et al., 1999; Melia et al., 2000).
Comparison of the amino acid sequence o f photoreceptor PDE with PDE2, PDE5, 
PDE 10 and PDE11 reveals the presence o f GAP domains (Aravind and Ponting, 1997) in 
the N-terminal half o f each PDE that encode noncatalytic cGMP binding sites 
(Charbonneau et al., 1990; McAilister-Lucas et al., 1993; Manganiello and Degerman, 
1999; Soderling and Beavo, 2000; Fawcett et al., 2000; Yuasa et al., 2000). In the case of
20
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PDE2, cGMP binding to these noncatalytic sites directly stimulates cyclic nucleotide 
hydrolysis at the active site (Martins et al., 1982; Yamamoto et al., 1983). For PDE5, the 
noncatalytic sites allosterically regulate accessibility o f  a phosphorylation site that alters 
catalytic activity (Bums et al., 1992; Turko et al., 1998; Corbin et al., 2000). The possible 
regulatory function for the low affinity, noncatalytic sites on PDE 10 is not known, nor is 
it known whether the GAF domains in PDE 11 represent functional cGMP binding sites.
Since the initial findings by Yamazaki et al. (Yamazaki et al., 1980; Yamazaki et 
al., 1982) that cGMP bound with high affinity to rod photoreceptor PDE, several possible 
roles for the noncatalytic sites on rod PDE have been proposed. One hypothesis is that 
cGMP occupancy o f the noncatalytic sites on PDE affects the strength o f the interaction 
between the inhibitory Py subunit and Pap  [reviewed in ref. (Artemyev et al., 1998)]. It 
has also been proposed that changes in cGMP binding affinity to the noncatalytic sites 
during visual transduction might permit the release o f bound cGMP to accelerate the 
restoration of cGMP levels during the recovery phase o f  the photoresponse (Cote and 
Brunnock, 1993; Yamazaki et al., 1996a). Finally, the idea that the noncatalytic sites on 
photoreceptor PDE might directly regulate hydrolysis o f  cGMP at the active site (as is the 
case for PDE2) has not been supported by current evidence (Arshavsky et al., 1992; 
D'Amours and Cote, 1999).
In this paper, we characterize the properties o f  non-activated, transducin- 
activated, and catalytic dimers o f PDE, all derived from suspensions o f purified 
amphibian rod outer segments, in order to provide a detailed account o f the changes that 
occur at the catalytic and noncatalytic domains of PDE upon light activation o f  the 
phototransduction cascade. We demonstrate a direct correlation between occupancy of
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cGMP at the noncatalytic sites o f PDE and the state o f association o f the inhibitory Py 
subunit. Our results are consistent with transducin activation reducing cGMP binding 
affinity primarily at one o f  the two high-affinity, noncatalytic sites on PDE. Furthermore, 
transducin activation o f  PDE cannot achieve the maximum catalytic potential o f PDE that 
is observed when the Py subunits are completely removed from the P ap  catalytic dimer. 
These changes in the noncatalytic and catalytic sites upon transducin activation are 
mediated through changes in Py interaction with PaP upon binding o f transducin to PDE. 
The coordinated, allosteric regulation of cGMP and Py binding to PaP upon transducin 
activation operate too slowly to play a role in the rapid events o f  rod phototransduction 
(i.e., excitation and recovery), but may be important in more slowly developing aspects 
o f light adaptation.
Experimental Procedure
Materials. Frogs (Rana catesbeiana) were obtained from Niles Biologicals. 
[3H]cGMP was from NEN Life Science Products. Membranes for filter binding assays 
were obtained from Millipore. Reagents, substrates and nitrocellulose membranes for 
immunoblotting were from Pierce Chemical Co. or from Bio-Rad. Silicone oils for 
centrifugal separation were obtained from the William F. Nye Co. All other chemicals 
were obtained from Sigma.
Preparation o f  Frog Rod Outer Segments (ROS) and recombinant bovine rod 
PDE inhibitory ysubunit (Py). Osmotically intact frog ROS were purified on a 
discontinuous Percoll density gradient exactly as described in ref. (Cote, 2000). Purified
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ROS were homogenized in Buffer A [containing: 77 mM KC1, 35 mM NaCl, 2.0 mM 
MgCI2, 1.0 mM CaCl2, 10 mM HEPES (pH 7.5), 2 mM dithiothreitol, 1 mM 4-(2- 
aminoethyl)-benzenesulfonyl fluoride, 5 pM leupeptin, and 1 pg/ml pepstatin] following 
the method o f Dumke et al. (Dumke et al., 1994). Homogenized ROS were incubated in 
the dark at room temperature for 20-30 min to allow endogenous nucleotide hydrolases to 
degrade cGMP and GTP levels prior to experimental manipulations. Following depletion 
o f  nucleotides and determination o f the rhodopsin concentration by difference 
spectroscopy (Bownds et al., 1971), ROS samples were exposed to light for subsequent 
steps (unless otherwise noted). The PDE concentration in ROS homogenates was 
determined by its ability to bind a maximum o f 2 mol cGMP per mol holoenzyme in its 
non-activated state when supplemented with stoichiometric amounts o f exogenous Py 
(see (Cote, 2000) for details).
Subcellular fractionation of ROS homogenates was typically performed by 
centrifuging samples for 1-3 min at 30 psig (110,000 x gaV) at room temperature using a 
Beckman Airfuge. We verified that the integral membrane protein, rhodopsin, was 
present in the supernatant at undetectable levels and that >95% of the total rhodopsin 
could be recovered in the membrane pellet under these conditions.
Recombinant bovine rod Py was expressed in E. coli and purified to >97% purity 
as described in ref. (Granovsky et al., 2000). The Py concentration was determined 
spectrophotometrically using an experimentally determined extinction coefficient o f  7550 
OD M '1 (Cote, 2000). The inhibitory activity o f purified Py was assayed by its ability to 
stoichiometrically inhibit trypsin-activated bovine rod PDE (Mou et al., 1999); the
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spectrophotometric and activity estimates of Py concentration agreed to within 10% for 
all Py preparations used in this study.
PDE preparations used in this study. Since PDE6 is the only detectible isoform 
of phosphodiesterase in purified ROS, no additional purification o f the rod PDE was 
required. Non-activated PDE (nPDE) was obtained directly from nucleotide-depleted 
ROS homogenates; in the absence of GTP, dark-adapted and light-exposed ROS 
homogenates show no difference in the rate o f cGMP hydrolysis or in the extent of 
cGMP binding. The catalytic activity of nPDE was typically 1-3% of the activated rate at 
the concentrations used in this paper (D'Amours and Cote, 1999). Transducin-activated 
PDE (taPDE) was prepared by incubating nucleotide-depleted ROS homogenates ([PDE] 
>12 nM; see (Dumke et al., 1994)) with an excess o f GTPyS relative to the transducin 
concentration [-30 transducins per PDE; (Hamm and Bownds, 1984)]. Trypsinized PDE 
(tPDE), in which the Py subunits are proteolytically digested to relieve their inhibitory 
constraint (Hurley and Stryer, 1982), was prepared by incubating ROS homogenates with 
TPCK-treated trypsin, followed by addition of a 6-fold molar excess of soybean trypsin 
inhibitor. The time course and concentration dependence o f activation was closely 
followed to determine the minimum exposure o f PDE to the pro tease yielding full 
activation (see Results). Excessive proteolysis o f  PDE leads to a gradual loss in the 
maximal catalytic activity, as well as irreversible damage to the noncatalytic sites. We 
prepared PDE heterodimers (Pap) depleted of Py by modifying the original method o f 
Yamazaki et al. (Yamazaki et al., 1990): nPDE was incubated with GTPyS for 60 min at 
4° to allow Py to dissociate from Pap, and then centrifuged in the Airfuge to pellet ROS
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membranes. The supernatant was discarded and the ROS membrane treated with GTPyS 
once more to further release membrane-bound Py. Following the second centrifugation, 
ROS membranes retained all o f  the original PaP content, but only 10-35% of the original 
Py (depending on the individual preparation). [The content o f  a t in GTPyS-washed ROS 
membranes was also reduced to <30% of its concentration in ROS homogenates, as 
judged by immunoblot analysis with anti-at antibodies.] P ap  was used immediately 
following its preparation, because the enzyme was unstable once most o f the Py had been 
removed. Only preparations containing <25% of the original Py content (i.e., < 0.5 Py per 
PDE) were used in experiments employing Pap. Efforts to completely eliminate Py from 
our Pap preparations were unsuccessful.
Binding o f  cGMP to noncatalytic sites on PDE. Because PDE is the only rod 
photoreceptor protein that binds cGMP with high affinity (Kd <  |xM) (Cote and 
Brunnock, 1993; Cote et al., 1994), we were able to measure changes in binding 
occupancy at the noncatalytic sites of PDE in unfractionated ROS homogenates. For most 
experiments, a cGMP filter binding assay (Cote, 2000) was used to quantify binding of 
[3H]cGMP to high affinity sites on PDE. Inclusion o f zaprinast or E4021 (D1 Amours et 
al., 1999) with the [3H]cGMP solution during the filter binding assay prevented cGMP 
breakdown during the incubation with nPDE or activated PDE. In some experiments, the 
cGMP binding reaction was halted by addition of ice-cold 95% saturated am m onium  
sulfate (Cote, 2000) prior to membrane filtration o f the quenched samples.
In order to directly correlate cGMP binding with Py binding to activated PDE 
(shown in Figure 2.4), we employed a centrifugal separation assay through a silicone oil
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layer that partitions free [3H]cGMP from bound nucleotide (Forget et al., 1993; Cote, 
2000). Portions (10 p.1) o f  ROS homogenates were layered on top o f  100 pi o f silicone oil 
(density, 1.020 g/ml) in a 5 x 20 mm centrifuge tube (Beckman) at 4°. The tubes were 
spun at room temperature for 3 min at 110,000 x gaV. Supernatants remaining above the 
oil layer were removed and processed for immunoblot analysis o f  Py concentration. The 
pellets were resuspended and one portion analyzed for Py content, while the other portion 
was used to quantitate bound [3H]cGMP.
Quantitative immunoblot analysis o fP y  concentration in ROS. Samples for Py 
analysis were added to electrophoresis sample buffer, and then subjected to sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). After electrophoretic 
transfer to a 0.45 pm nitrocellulose membrane, the presence o f  Py was detected with an 
affinity-purified rabbit polyclonal antibody (UNH9710-4P; 1:15,000 dilution) specific for 
amino acid residues 63-87 o f bovine rod Py. [Frog (Rana pipiens) Py has an identical 
amino acid sequence to bovine Py in this region; Wolfgang Baehr, personal 
communication.] Binding o f the Py antibody was determined using a goat anti-rabbit 
antibody coupled to horseradish peroxidase (1:4000 dilution), followed by incubation of 
the membrane with substrate (SuperSignal West Pico Chemiluminescent Substrate, 
Pierce) and luminescent detection on film (Kodak BioMax Light). The intensity of the Py 
immunoreactive bands was recorded using a scanner and analyzed using the image 
analysis program, Quantiscan (Biosoft). The concentration o f  Py in ROS samples was 
calculated by comparison to a standard curve generated with known amounts (0.5 -  15 
ng) of recombinant Py on the same blot, as described in detail elsewhere (Cote, 2000).
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PDE activity assay. The rate o f cGMP hydrolysis catalyzed by non-activated and 
activated forms o f  PDE was measured by a coupled-enzyme phosphate release assay, as 
described in detail in ref. (Cote, 2000). Activity measurements were made in the 
following buffer: 100 mM Tris, 10 mM MgCl2, 0.5 mM EDTA, 2 mM dithiothreitol, 0.5 
mg/ml bovine serum albumin, pH 7.5. In all cases, rate measurements were obtained 
from at least three individual time points at saturating cGMP concentrations (10 mM), 
during which time less than 30% of the substrate was consumed.
Other methods. SDS-PAGE was performed by the method o f Laemmli in 15% 
acrylamide gels (Laemmli, 1970). The immunoblotting protocol closely followed 
standard procedures (Gallagher, 1998). Fitting of PDE activity data was carried out with 
nonlinear regression analysis using Sigmaplot. Equilibrium binding data as well as the 
kinetics o f cGMP association and dissociation were analyzed as described in ref. (Cote, 
2000); in all cases, statistical comparisons o f one-site versus two-site fits were carried out 
using KELL (Biosoft) to determine whether PDE exhibited one or two distinct classes of 
cGMP binding sites.
Results and Discussion
Transducin activation o f  PDE converts one class o f  noncatalytic sites to a low 
affinity, rapidly exchanging state. While it has been reported that transducin activation of 
photoreceptor PDE leads to changes in cGMP binding to the noncatalytic sites o f the 
enzyme, the regulatory and physiological significance of this process is not well 
understood. A previous study reported that transducin activation o f PDE accelerated
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cGMP exchange and reduced the binding affinity of cGMP to the noncatalytic sites on 
the enzyme without a significant reduction in the stoichiometry of binding (Cote et al., 
1994). However, this work was conducted with PDE preparations supplemented with 
exogenous Py subunit that markedly affects the interaction o f cGMP with the noncatalytic 
sites (see below). Therefore, we chose to examine the cGMP binding properties o f 
nonactivated and transducin-activated PDE in ROS homogenates containing only the 
endogenous Py that is present in rod photoreceptor cells. We carried out equilibrium and 
kinetic studies at 4° to slow the binding reactions for accurate measurements o f the rate 
constants.
Non-activated, nucleotide-depleted PDE (nPDE) in frog ROS homogenates binds 
cGMP with high affinity and as a single class o f noninteracting binding sites at 4° (Kd — 
8.4 nM, Bjnax =1 .7  mol cGMP per mol PDE ; see Table 2.1). The measured Kd for cGMP 
binding to frog nPDE agrees with previous estimates when the temperature dependence 
o f the binding reaction is accounted for (Cote and Brunnock, 1993). [The Bmax o f nPDE 
can be increased to 2.0 by addition of < 1 Py per PDE (see Figure 2.2C), suggesting that a 
small amount o f Py was lost during preparation o f nPDE.] When transducin is activated 
by addition o f GTPyS to illuminated ROS homogenates and then 10 -  400 nM [3H]cGMP 
is added, transducin-activated PDE (taPDE) undergoes a 7-fold decrease in binding 
affinity (Kd = 57 nM) and a substantial loss in the number o f  cGMP binding sites (Bmax =
1.0 mol cGMP per mol PDE; Table 2.1). At higher [3H]cGMP concentrations up to 1.3 
pM, we detected an additional 0.3 mol cGMP bound per PDE, but could not 
resolve a distinct, second class o f binding sites. To improve detection o f  low affinity 
cGMP binding sites, we prepared high specific activity [32P]cGMP, and found that
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Table 2.1
Equilibrium and Kinetic Parameters for High Affinity cGMP Binding to Frog PDE*
Kd (obs.)b k-i° k+id
(nM) (sec'1) (M^sec"1)
nPDE 8.4 ± 1.8 (5) 3.4 ± 0.2 x 10"4 (7) 7.6 ± 0.8 x 104 (6)
taPDE slow:
57 + 9.4 (8)
3.4 ± 1.2 x 1C4; 64% (8)
7.8 + 0.8 x 104 (7)fast: 2.9 ± 0.9 x 10'3; 36% (8)
a Binding o f [3H]cGMP to non-activated PDE (nPDE) and transducin-activated PDE 
(taPDE) were performed at 4° as described in the Experimental Procedures. ROS 
homogenates were depleted o f nucleoside phosphates prior to use. Values represent the 
mean ± S.E.M for the number o f determinations shown in parentheses. 
b Equilibrium binding measurements of cGMP to nPDE were performed at 4° by mixing 
PDE (8-11 nM) with 1 -  400 nM [3H]cGMP and incubating for 30 min. Transducin- 
activated PDE (8-17 nM) was pre-incubated with GTPyS (added at a concentration equal 
to the rhodopsin concentration) for 1 min prior to addition of [3H]cGMP. The Bmax 
obtained from these binding isotherms was 1.73 ± 0.11 and 0.98 ± 0.11 mol cGMP per 
mol PDE for nPDE and taPDE, respectively. A second class of low affinity sites on 
taPDE was not detected in these experiments (see text).
c Dissociation rate constants (k-i) were determined as described in Fig. 1. Percentage 
values represent the proportion o f the total binding sites exhibiting rapid or slow cGMP 
dissociation with taPDE in a two-site fit o f the dissociation kinetics. 
d Association rate constants (k+i) were calculated from the kobs values in Fig. 1 using the 
equation: k+i = (kobs -  k.i)/[cGMP], where [cGMP] is the total cGMP concentration and 
ligand depletion is not significant (Hulme and Birdsall, 1992).
increasing the [32P]cGMP concentration from 1 p.M to 15 pM results in a progressive 
(K1/2 ~ 5 pM) increase in total cGMP binding to taPDE from 1.2 to 1.9 cGMP bound per 
PDE (data not shown). Low affinity cGMP binding sites were not detected with nPDE.
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Thus, activation o f  PDE by transducin induces heterogeneity in the noncatalytic sites on 
PDE, with a large decrease in binding affinity at one noncatalytic site, and a more modest 
change at the second site.
Measurements o f the rate o f cGMP association and dissociation were performed 
to better understand how transducin activation differentially affects cGMP binding to the 
two noncatalytic sites o f PDE. When PDE is incubated with 1 pM [3H]cGMP, a single 
class of cGMP binding sites is resolved (Figure 2.1 A), and the association rate constant is 
identical for nPDE and taPDE (Table 2.1). [The low affinity cGMP binding sites on 
taPDE (-0.2 cGMP per PDE under these conditions) apparently did not contribute 
sufficiently to be resolved in Figure 2.1 A.] Thus, transducin activation does not 
significantly alter the initial step o f cGMP binding to the moderate affinity class of sites 
on taPDE. The association rate constant for cGMP binding (k+i = 8xl04 M 'V )  is 
approximately 3 orders o f  magnitude below the diffusion-controlled limit for a simple 
bimolecular protein-ligand binding reaction (Gutfreund, 1995). Restricted diffusion o f 
cGMP to the binding pocket o f the noncatalytic sites may result from binding o f Py in 
proximity to the noncatalytic domains on Pap (Natochin and Artemyev, 1996).
Heterogeneity in the noncatalytic cGMP binding sites was readily observed 
(Figure 2.IB) when bound [3H]cGMP dissociated from taPDE (but not nPDE), in 
agreement with previous observations (Cote et al., 1994; Yamazaki et al., 1996a; Calvert 
et al., 1998). PDE activation accelerates 9-fold the exchange rate o f cGMP from 
approximately 0.4 cGMP per PDE, probably reflecting the low affinity sites that are not 
saturated under the conditions o f this experiment. The remaining two-thirds o f  the 
binding sites (0.8 cGMP per PDE) dissociate bound [3H]cGMP at the same rate as does
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Figure 2.1. The kinetics o f cGMP exchange at the noncatalytic sites o f non-activated and 
transducin-activated PDE. A. For measuring the kinetics o f cGMP association to nPDE, 
25 nM PDE was mixed with 1 fiM [3H]cGMP at 4°, and the binding reaction quenched 
with ice-cold ammonium sulfate at the indicated times (see “Experimental Procedures”). 
Transducin-activated PDE (taPDE) was prepared from non-activated PDE (nPDE) by 
pre-incubating samples with 1 mM GTPyS for 1 min prior to cGMP addition. The nPDE 
data are the mean ± S.E.M. for 6 experiments, and the curve is the fit o f the data to a 
pseudo first-order reaction (kobs = 7.7 ± 0.8 x 10'2 sec'1; Bmax = 1.83 ± 0.07 cGMP bound 
per PDE). For taPDE, the values are: kobs = 7.9 ± 0.8 x 10'2 sec'1; Bmax = 1.25 ± 0.08 
cGMP bound per PDE; n = 7). Note that a two-site model was not statistically preferred 
to the one-site model in all experiments examined. B. To measure the kinetics o f cGMP 
dissociation, 60 nM PDE (either non-activated or pre-incubated for 1 min with GTPyS as 
above) was first incubated with 1 jjM [3H]cGMP for 30 min at 4° to occupy the 
noncatalytic sites (nPDE: 1.7 cGMP bound per PDE; taPDE: 1.2 cGMP bound per PDE). 
At time zero, dissociation o f [3H]cGMP was initiated by addition o f 10 mM unlabeled
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cGMP, and samples were directly filtered at the indicated times. The data points are the 
mean ± SEM (n = 6), and the curves represent the fit o f  the data to a single exponential 
for nPDE (k_i = 3.4 x 1CF* sec"1) and a double exponential process for taPDE (36% fast 
sites, k_i = 2.9 x 10"3 sec'1; 64% slow sites, k_i = 3.4 x 10"4 sec"1). The dotted line 
demonstrates that the data for taPDE dissociation do not fit a single-site dissociation 
model.
nPDE. Thus, a  7-fold change in the Kd o f  the moderate affinity cGMP binding sites 
following transducin activation o f PDE fails to significantly affect the dissociation rate 
constant from these sites. The approximately 1000-fold lowering o f cGMP affinity to the 
second class o f  sites on taPDE has a relatively modest effect on the dissociation rate 
constant for this class of noncatalytic sites detected in Figure 2. IB.
We conclude that the nonactivated PDE holoenzyme consists o f two identical, 
high affinity cGMP binding sites. Furthermore, the excellent agreement between the 
observed Kd and the kinetic Kd (k.i/k+i = 4.5 nM) indicates that the association and 
dissociation reaction steps measured in Fig. 2.1 represent the rate-limiting steps for 
cGMP interaction with the noncatalytic sites on nPDE. Upon transducin activation o f 
PDE, heterogeneity in the noncatalytic sites becomes evident. The moderate affinity 
noncatalytic site on taPDE (Kd =  57 nM) retains the same kinetic rate constants for 
cGMP association and dissociation as observed for nPDE, indicating that some other 
rate-limiting process (e.g., conformational transition, protein-protein interaction, etc.) 
must contribute to destabilizing cGMP binding to this class o f  sites. The low affinity site 
can only be saturated at high cGMP concentrations (well above micromolar), and 
represents the small proportion o f more rapidly dissociating sites in Figure 2. IB. The 
creation o f two non-identical cGMP binding sites on upon PDE activation by transducin
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is likely to result from differences in how a t-GTPyS interacts with the a  and p catalytic 
subunits.
Exogenous P y  regulates cGMP exchange rates at both low and high affinity 
noncatalytic sites on PDE. To test the role o f Py to regulate cGMP binding to the 
noncatalytic sites on nPDE and taPDE, we examined whether adding Py affected cGMP 
dissociation from nPDE and taPDE. Figure 2.2A shows that when nPDE is incubated 
with increasing amounts o f  Py and then 1 pJvl [3H]cGMP is added to occupy the 
noncatalytic sites, the half-time for [3H]cGMP release is progressively slowed. The 
ability o f  Py to slow cGMP dissociation from nPDE is probably a consequence o f 
reducing (by mass action) the number o f PDE molecules lacking one or two bound Py at 
any moment in time. The sensitivity o f cGMP exchange on nPDE to the free Py 
concentration suggests a strong allosteric linkage between Py binding to PaP and cGMP 
occupancy o f the noncatalytic sites.
Pre-incubation o f taPDE with increasing amounts o f Py prior to transducin 
activation has two major effects on the noncatalytic cGMP binding sites. First, Py can 
convert low affinity cGMP binding sites on taPDE to high affinity sites (Figure 2.2C). 
Second, addition of increasing amounts o f Py can reduce (1 Py added per taPDE) or 
abolish (> 2 Py added per taPDE) the rapidly dissociating class o f noncatalytic sites on 
taPDE, as well as slowing cGMP dissociation from the other class o f sites to a similar 
extent as nPDE (Figure 2.2B). It is noteworthy that Py exerts these effects on the 
noncatalytic cGMP binding sites with greater potency than it can inhibit catalysis at the 
active site o f taPDE (see Figure 2.7).
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Figure 2.2. Effects o f exogenous Py on cGMP dissociation from noncatalytic sites and on 
the maximum extent o f cGMP binding to nPDE and taPDE. ROS homogenates (20 nM 
PDE, final concentration) were incubated at 4° for —4 min with the following 
concentrations o f Py: 0 (circle), 1.0 (square), 2.0 (triangle), 5.0 (diamond) or 20 (upside- 
down triangle) mol Py per mol PDE. For transducin-activated PDE (panel B), the ROS 
were then incubated with 1 mM GTPyS for 1 min. Following addition o f 1 pM
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[3H]cGMP for 30 min at 4°, samples were tested for the maximum extent o f cGMP 
binding (panel C). [3H]cGMP dissociation was initiated upon addition o f  10 mM 
unlabeled cGMP at time zero and then portions were directly filtered at the indicated 
times. For nPDE (panel A), the data were best fit to a single exponential decay with the 
dissociation rates progressively slowing from the control value o f  t\n  = 34 m in to a t\a  = 
196 min for the 20 Py per PDE condition. For taPDE, a two-site model for the 
dissociation kinetics was preferred for the 0 and 1 Py per PDE conditions, with the 
percentage o f the total binding that can be attributed to the “fast” sites d im in ish ing  from 
35% to <10% as the amount o f added Py increased from 0 to 2 Py per PDE. The data are 
the mean ± SEM for three to six determinations o f the dissociation rates for each 
concentration o f  added Py.
Quantitative analysis o f  the P y concentration and its subcellular location in 
purifiedfrog ROS. Because free Py greatly affects cGMP binding and exchange kinetics 
with PDE, we decided to measure the Py concentration in intact frog ROS as well as the 
stoichiometry o f Py binding to frog Pap. Using a quantitative immunoblot procedure, we 
found that homogenates derived from Percoll-purified frog ROS contained 1.81 ±0.13 
(mean ± S.E.M.; n = 14) mol o f Py relative to the total concentration o f PDE holoenzyme 
(Figure 2.3, “Homog.”). Upon fractionation o f these ROS homogenates into membrane 
and soluble fractions by centrifugation, both dark-adapted and light-exposed ROS 
retain all Py (1.9 — 2.0 Py per PaP) in a membrane-associated state, and < 0.1 Py per PaP 
in the soluble fractions (Figure 2.3, “Control”). The membrane-associated Py was bound 
to PDE, because when frog PDE was released from ROS membranes by hypotonic 
extraction, a similar stoichiometry of Py binding to the released PDE was observed (data 
not shown).
Addition o f cGMP to saturate the noncatalytic sites on PDE did not alter the 
membrane-associated state or stoichiometry o f  Py binding to dark-adapted or light-
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Control +cGMP +GTPyS +cGMP & Homog.
GTPyS
Figure 2.3. Py content o f membrane and supernatant fractions o f frog ROS homogenates. 
ROS homogenates (120 nM PDE holoenzyme) in Buffer A were incubated at 4° for 30 
sec with: no additions (“Control”), 2.2 mM cGMP (“+cGMP”), 50 jrM GTPyS 
(“+GTPyS”), or both nucleotides supplemented with 50 jjM  zaprinast (“+cG&GTPyS”). 
Identical portions were either kept dark-adapted (black bars) or exposed to room light 
(gray bars) during the incubation period, and then samples were centrifuged for 1 min at
110,000 x g at ambient temperature. Supernatant (s) and membrane (m) samples were 
processed on different gels, along with a set o f Py standards on each gel, to quantitate the 
Py content (see “Experimental Procedures”). Unfractionated, dark-adapted ROS 
homogenates with no additions (“Homog.”) were also analyzed along with the membrane 
samples for the sake of comparison. In the representative immunoblot shown in the 
figure, the supernatant samples were exposed to film for longer times than the membrane 
samples to permit detection o f lower amounts of immunoreactivity. The * indicates that 
the amount o f  Py was below the level of detection. The data represent the mean ± S.E.M. 
for three experiments with different ROS homogenates. This figure was done in 
collaboration with Tracy Hebert and Marc D ’Amours.
exposed PDE (1.9 -  2.0 Py per Pap; Figure 2.3, “+cGMP”). However, if  light-exposed 
ROS homogenates are incubated with GTPyS to activate transducin, a substantial release 
o f Py into the supernatant fraction occurs shortly after nucleotide addition (0.8 ±  0.1 mol 
Py released per mol PaP). This Py dissociation into the supernatant can be prevented if
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millimolar levels o f cGMP are included with GTPyS (0.1 Py released per Pap; Figure 
2.3). Our quantitative analysis o f Py agrees with and extends the qualitative observations 
of Arshavsky et al. who first showed that occupancy of the noncatalytic sites by cGMP 
could prevent Py release from ROS membranes following transducin activation 
(Arshavsky et al., 1992).
We conclude that the frog rod PDE holoenzyme consists o f a PaP catalytic dimer 
to which 2 Py subunits bind, identical to the apyi stoichiometry o f membrane-associated 
bovine rod PDE holoenzyme (Deterre et al., 1988; Fung et al., 1990). The absence o f  Py 
in the ROS cytosol may reflect a tightly regulated, coordinated synthesis o f catalytic and 
inhibitory subunits o f PDE [as suggested by Py knockout experiments (Tsang et al., 
1996)]. The fact that approximately 1 mol Py per mol Pap can be released within 1 min 
of light activation o f PDE (Figure 2.3, “+GTPyS” condition) led us to hypothesize that 
the state of association of Py and cGMP with the PDE holoenzyme m ay be tightly 
coupled upon PDE activation by transducin.
cGMP dissociation from  noncatalytic sites correlates with P y  release following 
transducin activation o f  PDE. To test whether cGMP dissociation from noncatalytic sites 
is directly correlated with Py release from taPDE, we examined the time course o f cGMP 
dissociation and o f Py release following transducin activation o f PDE under conditions 
where the free cGMP concentration was rapidly reduced from its “dark-adapted” 
concentration (2 |iM). To activate PDE and simultaneously lower the free cGMP 
concentration, we employed a “concentration jump” technique (Calvert et al., 1998) in 
which GTPyS was added (to activate frog rod PDE) along with activated PDE1 (to
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rapidly hydrolyze free cGMP). Release of Py and cGMP from PDE were determined by 
centrifugation o f samples through silicone oil and analysis o f the pellets for the amount o f  
[3H]cGMP or Py bound to the membrane-associated PDE. We found that the time course 
o f cGMP dissociation following transducin activation closely tracked the rate o f Py 







0 5 2010 15 25 30 60
Time after onset of nPDE activation (min)
Figure 2.4. Py dissociation from transducin-activated PDE correlates with cGMP 
dissociation from noncatalytic binding sites. ROS homogenates (30-120 nM PDE) were 
incubated with 2 pM cGMP or [3H]cGMP and 3 pM E4021 for 10 min at 4°. Transducin 
activation o f PDE and dissociation o f its bound cGMP was initiated upon addition o f 100 
pM GTPyS, 103 U/l PDE1, and 8xl04 U/l calmodulin (final concentrations). [In control 
experiments similar to those o f Calvert et al., Fig. 5 A (Calvert et al., 1998), we 
determined that PDE1 activities ranging from 500 to 4000 U/l resulted in identical cGMP 
dissociation kinetics.] At the indicated times, portions were centrifuged for 1 min at
110,000 x g at room temperature. The membrane pellet was then analyzed for either Py 
content (•) or [3H]cGMP binding (o). The data points represent the mean ± S.E.M. for 
four experiments where Py and [3H]cGMP were both measured on the same preparation. 
The curves represent the fit o f  the data to a 2-site binding model: for Py release: 30 ± 5% 
o f the Py rapidly dissociated (tj/2 = 0.6 ± 0.2 min) and 70 ± 3% o f the Py slowly 
dissociated (tj/2  =  39 ± 6 min); for cGMP dissociation, 20 ± 7% was rapidly released (ti/2  
= 0.7 ±  0.6 min) while 80 ± 5% slowly dissociated (ti/2 = 65 ± 15 min). This figure was 
done in collaboration with Tracy Hebert and Marc D ’Amours.
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o f the reaction occurring rapidly (t\n = 0.6 -  0.7 min), and the remainder o f the 
dissociation reaction occurring much more slowly (ti/2  = 40-60 min).
Experimental limitations prevented us from determining the temporal sequence of 
Py and cGMP dissociation from Pap. However, it is likely that interaction o f a t-GTPyS 
with Py bound to the PDE holoenzyme initially displaces Py from its tight association 
with one catalytic subunit, thereby accelerating cGMP dissociation from the noncatalytic 
site. Loss o f cGMP at this noncatalytic site would further lower the Py binding affinity 
for Pap, leading to dissociation o f Py-at-GTPyS from Pap . The observation that cGMP 
and Py dissociation from the other class o f binding sites proceeds as slowly as for nPDE 
(Figure 2.IB) indicates that a t-GTPyS is much less effective in binding to the second Py 
molecule and accelerating cGMP exchange at this noncatalytic site. This might be 
explained if  the remaining Py bound with higher intrinsic affinity to PaP than the Py that 
is rapidly released.
c GMP occupancy o f  the noncatalytic sites induces stoichiometric binding o f  P yto  
taPDE. We next asked whether occupancy of the noncatalytic cGMP binding sites on 
taPDE was sufficient to reverse Py dissociation from Pap. We first prepared taPDE 
lacking bound cGMP, and then added increasing concentrations o f  [3H]cGMP. After 
centrifuging the PDE-containing ROS membranes, we simultaneously assayed the extent 
of [3H]cGMP binding and the stoichiometry o f Py binding to taPDE. Figure 2.5 
demonstrates a one-to-one correlation between cGMP occupancy o f  the high affinity 
noncatalytic sites and Py binding to Pap. In the absence o f cGMP, taPDE bound 0.2 mol 
Py per mol PDE. As increasing concentrations o f cGMP were added, taPDE displayed a n
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= 4) and a single class o f Py binding sites (Bmax = 1.4 ± 0.1 Py bound per PDE; n = 4). 
When incubated with high concentrations o f cGMP to occupy both high and low affinity 
cGMP binding sites on taPDE, the Py binding stoichiometry approached the same value 
as for nPDE (Figure 2.3, “+cGMP & GTPyS”).
We conclude that cGMP occupancy of the noncatalytic sites must induce a 
conformational change in the PaP catalytic dimer that enhances Py binding to Pap. This 
allosteric effect o f cGMP to enhance Py binding affinity does not act on the C-terminal 
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Figure 2.5. Endogenous Py binding to transducin-activated PDE correlates with titration 
of cGMP binding to the noncatalytic sites. PDE (15 nM) was transducin-activated by the 
addition o f 10 pM GTPyS 1 minute prior to the addition o f increasing amounts of 
[3H]cGMP (with 200 pM zaprinast). After a 30 min incubation, two portions were 
quenched into ice-cold buffered ammonium sulfate (see Experimental Procedures) to 
determine the [3H]cGMP content (closed circle). The remaining portion was spun for 1 
min at 110,000 x g. The supernatants were discarded, and the pellets were washed once 
and then analyzed for their Py content (open circle). For the cGMP binding data, the 
curve is a 2-parameter hyperbolic fit with Bmax =1.3 cGMP bound per PDE and a Kd = 
65 nM, while the Py binding curve parameters are: Bmax = 1.1 Py per PDE and K 1/2 = 34 
nM cGMP. The data shown are representative of 4 individual experiments.
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single class o f high affinity cGMP binding sites (Bmax = 1.3 ±0.1 cGMP bound per PDE; 
activated (see Table 2.2). Rather, a distinct domain on Py [e.g., the central polycationic 
domain; (Artemyev and Hamm, 1992)] must be involved in interacting with PaP in a 
cGMP-dependent manner.
Two distinct classes o f  Py binding sites on Paf5 restore high affinity cGMP 
binding to the noncatalytic sites. To understand the basis of the heterogeneity in the 
noncatalytic sites o f taPDE, we needed to study the binding o f cGMP and Py to catalytic 
dimers (Pap) from which Py had been completely removed. Previous work had 
demonstrated that physical removal o f Py from frog rod PDE following transducin 
activation resulted in a loss of cGMP binding, and that addition of Py restored high 
affinity cGMP binding to noncatalytic sites (Yamazaki et al., 1982; Cote et al., 1994; 
Yamazaki et al., 1996b). However, heterogeneity in Py binding to frog P aP  has been 
reported in some cases (Yamazaki et al., 1996b; Yamazaki et al., 1996a) but not in others 
(Yamazaki et al., 1982; Cote et al., 1994).
Two independent approaches were used to prepare PaP catalytic dimers from 
which Py had been removed. The first method is based on the ability o f activated 
transducin to release 50 -  70% of its Py when the noncatalytic sites are empty (Yamazaki 
et al., 1990). [We further optimized the conditions for Py removal from P aP  to further 
reduce the amount of Py associated with PaP to 10 — 25% o f  the original amount (see 
“Experimental Procedures” and Fig. 2.4).] The second approach to preparing PaP  dimers
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relied on the ability o f trypsin proteolysis to degrade Py without adversely affecting the 
functional properties o f Pap at its catalytic or noncatalytic sites (Mou et al., 1999).
Figure 2.6 demonstrates that when we prepared Pap catalytic dimers by either 
method, addition o f Py to PaP in the presence o f  1 pM [3H]cGMP restores high affinity 
cGMP binding to the noncatalytic sites in a biphasic manner. Addition of < 1 mol Py per 
PaP results in equimolar cGMP binding to high affinity sites on Pap. Thereafter, only a 
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Figure 2.6. The restoration of high affinity cGMP binding to PDE catalytic dimers by Py 
reveals two classes of binding sites. Activated PDE was prepared either by extraction o f 
Py from P ap  by a t-GTPyS (closed circles, n = 5) or by trypsin proteolysis (2.5 pg/ml 
trypsin for 5 min at 4°) to make tPDE (open circles, n = 3), as described in “Experimental 
Procedures”. The residual Py content was 16 ± 2% for PaP, and 22 ± 2% for tPDE. The 
indicated concentration of Py was incubated with 10 nM PaP (closed circles) or 17 nM 
tPDE (open circles) for 5 minutes before adding 1 pM [3H]cGMP plus 200 pM zaprinast. 
The samples were incubated for 30 min at 4°, then analyzed for the amount o f [3H]cGMP 
bound to the enzyme. The dashed line represents the results that would have been seen if  
the restoration o f  high affinity cGMP binding by Py occurred in a simple one-to-one 
stoichiometry.
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noteworthy that adding exactly 2 mol exogenous Py per mol PaP in Figure 2.6 leads to 
the same extent o f cGMP binding (1.2 cGMP per PDE) as is seen for taPDE samples 
(containing 2 mol endogenous Py per mol PDE) under similar conditions (Table 2.1, 
Figure 2.2C, Fig. 2.5). Addition o f > 4 Py per Pap  fully restores cGMP binding to a 
second class of sites that were unoccupied at lower Py concentrations (consistent with the 
results in Figure 2.2C for taPDE). The results shown in Figure 2.6 were also observed 
when PaP was prepared by activating transducin with GTP instead of GTPyS (data not 
shown). The data in Figure 2.6 are in good agreement with previously published data 
(Cote et al., 1994); the more extensive data set and greater precision in determining PDE 
subunit concentrations in Figure 2.6 probably account for our ability to resolve the 
biphasic behavior that was overlooked in the earlier study.
The results in Figure 2.6 demonstrate that Pap  contains two distinct classes o f Py 
binding sites. One class o f Py binding sites has very high affinity for PaP in the presence 
o f 1 jjM  cGMP, and can bind up to 1 Py per PaP as a simple titration phenomenon. The 
noncatalytic cGMP binding sites that are restored by stoichiometric Py addition 
correspond to the moderate affinity class of sites found in taPDE (Table 2.1, Figure 2.5). 
The second class o f Py binding sites on PaP are o f lower affinity and requires an excess 
o f Py (when the cGMP concentration is < 1 pM) in order to shift the equilibrium to the 
liganded state. This lower affinity class o f Py binding sites is very likely responsible for 
converting low affinity noncatalytic cGMP binding sites on taPDE to their high affinity 
state (Figure 2.2C). Although it is probable that the a  and P catalytic subunits o f frog 
PDE have binding domains for Py with intrinsically different binding affinities [as
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reported for Py binding to bovine rod PDE; (Berger et al., 1999)], we cannot rule out 
allosteric mechanisms that might induce heterogeneity in Py binding to Pa(3.
Transducin activation fails to stimulate the maximum catalytic potential o f the 
P a p  catalytic heterodimer. Based on the above results, we hypothesized that 
heterogeneity in Py binding to Pap  might also result in differences in catalysis at the two 
active sites on Pap. While most previous work has assumed that each catalytic subunit 
contributes equally to catalysis upon activation of PDE by transducin, there is wide 
variation in the reported maximal hydrolytic rates for activated PDE [see Table V in 
(Pugh, Jr. and Lamb, 1993)] as well as uncertainty in the stoichiometry and cooperativity 
o f transducin activation o f PDE [see (Melia et al., 2000) and references cited therein].
We compared the rates o f cGMP hydrolysis for various forms o f activated PDE 
that differed in the method by which the inhibitory constraint of Py was relieved. To 
determine the maximum hydrolytic rate of taPDE, we measured the enzyme activity in 
light-exposed ROS homogenates following addition o f increasing concentrations o f 
GTPyS. Complete activation o f PDE by transducin required a concentration of GTPyS 
sufficient to activate the entire pool o f  transducin in ROS (data not shown). The kcat for 
taPDE, 4560 ± 140 cGMP per s (Table 2.2) is not significantly different from a previous 
estimate o f 4400 cGMP per s (Dumke et al., 1994).
We used the same frog ROS homogenates to directly compare taPDE with PDE 
activated by trypsin proteolysis (tPDE). We found that the kcat in the latter case was 
substantially higher, in contrast to previous comparisons using frog PDE (Whalen and 
Bitensky, 1989; Whalen et al., 1990). In one set o f experiments where we added
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increasing concentrations o f  trypsin to 2 nM PDE, we found a maximum catalytic rate o f 
7640 ± 140  cGMP hydrolyzed per s (n = 5; data not shown). In additional experiments 
where hydrolytic activity measurements were made at relatively low tPDE concentrations 
(0.5 to 3 nM PDE), we observed similarly high rates (Table 2.2). I f  hydrolytic activity o f 
tPDE was assayed at substantially higher enzyme concentrations (15 — 30 nM tPDE), the 
maximal rate approached the kcat for taPDE (Table 2.2). In a separate experiment,
Table 2.2
S u m m a r y  o f  M a x im a l  A c t iv it ie s  f o r  V a r io u s  P r e p a r a t io n s  o f
A c t i v a t e d  Fro g  PDE
PDE preparation3 [PDEf
(nM)
Maximum catalytic activity0 
(cGMP per s per PDE)
n
taPDE
> 12 4400 ref.
(Dumke et 
al., 1994)
1 2 -2 0 4560 ± 140 10
tPDE




0 .5 -3 .0 7550± 110 23
1 5 -3 0 4990 ± 375 5
Pap 1 - 2 7000 ± 180d 8
aPDE activated by transducin (taPDE), trypsin proteolysis (tPDE), or Py extraction by a t- 
GTPyS (PaP) was prepared as described in the “Experimental Procedures.” 
bThe concentration o f PDE used to assay the hydrolytic rate.
'Determined by measuring catalysis in the presence o f saturating levels o f cGMP (~100 
times the Km). The values are normalized to the concentration o f PDE catalytic dimer in 
each instance.
dThe maximal rate was calculated by correcting the observed rate in each experiment for 
the residual Py (15 -  25%) remaining bound to PaP , assuming a linear dependence o f the 
observed rate with the Py content (see Fig. 2.7).
This table was done in collaboration with Marc D ’Amours.
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progressive dilution o f tPDE from 3 nM to 0.5 nM caused the hydrolytic activity to 
increase from 6400 to 8100 cGMP per s per PDE; further dilution to 6 pM tPDE had no 
further effect on the apparent kcat- We attribute this phenomenon to the presence 
of proteolytic fragments o f Py in our tPDE preparations that retain the ability to bind to 
and inhibit P ap  at high, but not low, PDE concentrations. A 4.6 kDa Py-immunoreactive 
band [corresponding to amino acids 46 to 87 o f  bovine Py (Artemyev and Hamm, 1992)] 
has been detected on immunoblots o f tPDE preparations, and co-purifies with tPDE 
following gel filtration chromatography (data not shown).
We have also measured the maximal cGMP hydrolytic rates o f PaP preparations 
in which 75 -  85% o f the endogenous Py has been extracted by a r GTPyS. We find 
catalytic rates substantially greater (range, 5000 -  6600 cGMP per s) than the kcat for 
taPDE. When corrected for the residual Py content o f these PaP  preparations, the 
predicted kcat o f PaP dimer devoid o f Py is 7000 ± 180  cGMP per sec (n = 8; Table 2.2). 
Trypsinization o f these PaP preparations containing residual Py can further elevate the 
hydrolytic rate approximately 25%.
We conclude that the maximum catalytic potential o f the PaP catalytic dimer 
approaches 8000 cGMP hydrolyzed per s per PaP  when all Py is released from the 
enzyme. If we assume each catalytic subunit has the same turnover number (4000 cGMP 
per s per subunit) and the KM for tPDE is 22 pM (D'Amours and Cote, 1999), the 
specificity constant, kcat/KM is calculated to be 1.8 x 108 M 'V 1. Thus, the catalysis of 
cGMP into 5’-GMP occurs with extremely high catalytic efficiency and very near the 
diffusion limit (Gutfreund, 1995). However, PDE never achieves this level of activation
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in vivo, because transducin activation of the enzyme fails to fully relieve Py inhibition at 
both active sites. Rather, a t-GTPyS acts to completely relieve inhibition at only one of the 
two active sites on P ap , with perhaps a minor (< 10%) effect at the second catalytic site. 
Activation o f PDE catalysis by one, not two, activated transducin molecules in frog ROS 
homogenates is consistent with the 1:1 stoichiometry o f bovine rod PDE activation by 
transducin in a purified, reconstituted system (Melia et al., 2000).
Exogenous Pycan stoichiometrically inhibit Pa{3 catalytic dimers, but not taPDE.
To further probe how transducin binds to and activates the PDE holoenzyme, we 
examined the ability o f exogenous Py to inhibit the various forms of activated PDE used 
in this paper. Previous studies using tPDE or Pap preparations offer conflicting views on 
the ability of Py to inhibit activated frog PDE. In some reports, activated PDE can be 
inhibited by Py as a single class of high affinity sites (Yamazaki et al., 1996b; Yamazaki 
et al., 1996a), exhibiting the same titration behavior observed with bovine tPDE [e.g., 
refs. (Wensel and Stryer, 1986; Brown and Stryer, 1989; Mou et al., 1999)]. Other studies 
with activated frog PDE show evidence for lower affinity Py binding and/or complex 
inhibition of catalysis by added Py (Yamazaki et al., 1982; Whalen and Bitensky, 1989; 
Yamazaki et al., 1990). These differing results may arise from a number of factors, 
including the concentration o f PDE catalytic subunits used, residual Py in the activated 
PDE preparations, and uncertainties in determining the active P ap  and/or Py 
concentrations.
To resolve these discrepancies, we examined the ability o f  Py to inhibit activated 
PDE under conditions where the catalytic and inhibitory subunit concentrations were
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precisely determined. Figure 2.7 shows that PDE activated by transducin responds quite 
differently to the addition o f Py than do tPDE or P ap  preparations. Both tPDE and PaP 
are stoichiometrically inhibited by 2 mol Py per mol Pap. The steep linear dependence o f 
tPDE and PaP activity on the Py concentration reflects a titration phenomenon consistent 
with the sub-nanomolar binding affinity o f Py for frog PDE reported previously 
(D'Amours and Cote, 1999). The similar behavior for tPDE and PaP  in Figure 2.7 shows 
that trypsinization o f PDE acts primarily on Py and has no noticeable effect on the ability 
o f PaP subunits to be inhibited by added Py. Although a t-GTPyS is present in our PaP 
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Figure 2.7. Stoichiometric Py inhibition o f catalysis is observed with tPDE and PaP, but 
not with taPDE. tPDE (5 nM) was activated by trypsin treatment (200 pg/ml trypsin for 
10 min at 4°; see Experimental Procedures) and then incubated with the indicated amount 
o f Py. taPDE was prepared by first incubating nPDE (30 nM) with the indicated amounts 
of Py for 2 min prior to addition of 1 mM GTPyS for 1 min at 22°. P aP  dimers depleted 
o f >70% of its endogenous Py was prepared by two successive extractions o f  Py with 
GTPyS followed by centrifugation (see Experimental Procedures). PaP  (1 nM) was then 
incubated with the indicated concentrations o f exogenous Py. PDE catalytic activity was 
measured with 10 mM cGMP as substrate, and the rates normalized to the maximum 
value obtained in the absence o f  added Py. The curves represent a 3-parameter logistic 
curve fit to the data with IC50  values o f 0.9, 0.9, and 7.1 Py per PDE for tPDE, PaP, and 
taPDE, respectively.
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(Yamazaki et al., 1990), the stoichiometric inhibition o f  PaP  by Py demonstrates that a t- ■ 
GTPyS cannot compete effectively with PaP for binding to Py under these conditions. 
Thus, in both instances where activated PDE has had its Py physically removed from the 
catalytic dimer, exogenous Py has free access to and high affinity for the catalytic sites 
and can stoichiometrically inhibit catalysis.
In contrast, the inhibition o f taPDE by addition o f Py requires a greater than 15- 
fold molar excess o f Py to fully inhibit catalytic activity (Figure 2.7). The potency o f Py 
inhibition at the active site is several-fold weaker than its ability to convert low affinity 
noncatalytic binding sites on taPDE to higher affinity sites (Figure 2.2C). Note that in the 
presence o f millimolar levels o f cGMP in Figure 2.7, taPDE binds 2 mol endogenous Py 
per mol PDE (Figure 2.3), and has a catalytic activity about one-half of the maximal rate 
o f PaP (Table 2.2). It is likely, therefore, that taPDE exists as a complex o f a t-GTPyS 
with the PDE holoenzyme. We speculate that a molecule o f  a t-GTPyS, in a complex with 
Py and a catalytic subunit, hinders the free diffusion o f exogenous Py to its inhibitory 
binding site, thereby reducing the effectiveness o f free Py to inhibit cGMP hydrolysis 
compared to tPDE or P ap  preparations.
Role o f  the noncatalytic cGMP binding sites during transducin activation ofPDE. 
Our results suggest that the noncatalytic sites on photoreceptor PDE detect changes in 
cytoplasmic cGMP concentration during phototransduction, and allosterically regulate 
the state o f association o f  Py with PDE and with activated transducin. In the dark-adapted 
state, cGMP levels in rod photoreceptors are much higher (> 1 pM) than the Kd for 
cGMP binding to the noncatalytic sites of nPDE. Consequently, Py remains bound to both
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Figure 2.8. Model for activation o f rod photoreceptor PDE holoenzyme by transducin. 
The nonactivated form of the PDE holoenzyme (nPDE) is depicted with the right-hand 
catalytic subunit having a higher affinity for Py. Following binding of activated 
transducin (ar*) to the PDE holoenzyme, the inhibitory constraint o f Py is released at the 
active site (notch) on the left-hand catalytic subunit (lower Py binding affinity). In the 
presence o f high cGMP concentrations, noncatalytic sites (semi-circles) remain occupied 
and Py remains bound to both subunits (“taPDE-A”). Lowering the cGMP concentrations 
causes a transition to taPDE-B in which cGMP dissociates from its low affinity 
noncatalytic site (left side), and Py dissociation accompanies cGMP release. The right- 
hand subunit o f taPDE-B retains bound cGMP and Py because o f its intrinsically higher 
binding affinity for both molecules, and little relief o f inhibition occurs at this active site. 
See text for details.
catalytic subunits in its inhibitory conformation, and cGMP and Py exchange between the 
bound and free states is expected to be very slow (Figure 2.8, “nPDE”).
Transient light activation of the visual excitation pathway causes activated a t to 
displace Py from its inhibitory conformation, and cGMP rapidly drops below micromolar 
levels. However, the recovery of the dark-adapted state in response to dim flashes (time 
scale, seconds) probably restores cGMP levels (via guanylate cyclase activation) more 
rapidly than cGMP can dissociate from noncatalytic sites. Under these conditions, 
activated PDE would consist of a complex o f PDE holoenzyme (both noncatalytic sites 
occupied, both Py bound to PaP, and one catalytic site fully active; Figure 2.8, “taPDE-
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A”) and activated a t. PDE inactivation would depend upon the intrinsic GTPase rate o f 
transducin converting activated a t-GTP to inactive a t-GDP.
Persistent activation o f the phototransduction cascade by continuous illumination 
or bright flashes o f light causes cytoplasmic cGMP levels to remain below the Kd for the 
low affinity sites on taPDE long enough for cGMP to dissociate from the low affinity 
noncatalytic sites. Py dissociation will occur at the same rate because o f the highly 
cooperative nature o f Py and cGMP binding to PDE (Figure 2.8, “taPDE-B”)- The Py that 
is released is known to serve as a GTPase-accelerating factor for a t-GTP— in 
combination with the Regulator o f G-protein Signaling-9 (RGS-9) and the G-protein Psl 
subunit (Arshavsky and Bownds, 1992; He et al., 1998; Makino et al., 1999). This would 
speed up transducin inactivation, diminish the amplitude of the light response, and act as 
a feedback regulator for light adaptation.
Our model predicts that the second catalytic subunit of the PDE holoenzyme 
remains relatively unaffected by activation o f the rod phototransduction cascade, in terms 
of catalytic activation, Py release, or cGMP dissociation (Figure 2.8, right-hand subunit). 
Only under certain in vitro conditions does this subunit undergo changes in ligand 
binding or catalytic activity. A higher intrinsic affinity of this catalytic subunit for Py may 
account for this phenomenon.
Additional experiments are needed to test the hypothesis that the noncatalytic 
sites on PDE serve as a detector o f the cGMP concentration in rod photoreceptors during 
light adaptation. Future work will focus on better understanding the properties o f the low 
affinity noncatalytic sites on activated PDE, identifying the structural basis for catalytic
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subunit heterogeneity, and examining whether the homodimeric cone PDE employs 
similar regulatory mechanisms in cone photoreceptors.
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CHAPTER 3
ROLE OF THE 17 kDa 5 PROTEIN AND IMMUNOLOGIC ALLY 
RELATED PROTEINS IN REGULATION OF PDE IN ROD 
PHOTORECEPTORS
Summary
In rod photoreceptors, the disk membrane is the site where photo-isomerization o f 
rhodopsin by light leads to activation of the photoreceptor phosphodiesterase (PDE) by 
the heterotrimeric G-protein, transducin. The PDE holoenzyme (aPy 2 ) has been reported 
to exist in both a membrane-attached and soluble form. Isoprenylation of the catalytic 
subunit C-termini confers disk membrane association to PDE, while soluble PDE is 
found to bind a 17 kDa 5 “subunit.” It has been proposed that 8 translocates PDE from 
the disk membrane, reducing its ability to be activated by transducin, and desensitizing 
the photoresponse. Using purified, intact amphibian rod outer segment (ROS) 
suspensions whose physiological and biochemical properties are well-characterized, we 
examined the occurrence, abundance, and regulatory significance o f  the 17 kDa 5 protein 
to regulate PDE in rod photoreceptors. The frog homologue o f 8 was cloned and 
sequenced from a frog retinal cDNA library, and shows 83% amino acid identity to 
mammalian 8. All o f the PDE in frog ROS is membrane-associated, but addition of 
recombinant frog 8 can solubilize PDE and prevent its activation by transducin.
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Antibodies to 5 detect several proteins present in frog retinal homogenates, but the 
abundance o f the 17 kDa protein compared to PDE in purified frog ROS is low (<0.1 8 
per PDE). Similarly low ratios o f 8 to PDE are observed in purified bovine ROS. 
Immunocytochemical results show that 8 is localized to several retinal cell types, but not 
to rod outer segments. Higher molecular weight S-immunoreactive bands observed in 
frog and bovine ROS were analyzed for specific binding to PDE with negative results.
We conclude that frog rod photoreceptors do not utilize the 17 kDa 8 protein or 
immunologically related proteins to regulate phototransduction. Although we cannot rule 
out species differences in regulation o f phototransduction pathways by 8 in mammalian 
and amphibian photoreceptors, our results suggest that 8 is not involved in 
phototransduction in ROS and that its function in the retina remains to be determined.
Introduction
The surface o f the disk membranes of the outer segment is the initial site of visual 
transduction in rod photoreceptors. Light entering the cell is absorbed by the visual 
pigment, rhodopsin. The activation o f rhodopsin allows it to catalyze the exchange of 
GDP for GTP on the a-subunit o f  the heterotrimeric G-protein, transducin (Ta). Ta- 
GTP dissociates from Tpy and activates the effector enzyme o f  the pathway, 
phosphodiesterase (PDE). PDE hydrolyzes cGMP, closing the cGMP-gated ion channels 
and causing hyperpolarization o f the cell [for recent reviews, see Pugh, Jr. and Lamb, 
(2000); Bums and Baylor, (2001)].
Rod photoreceptor PDE is composed of a catalytic dimer o f a  and p subunits 
(PaP) and two identical inhibitory y subunits (Py). The catalytic subunits each have one
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active site and one high-affinity noncatalytic cGMP binding site within the regulatory 
GAF domain. Each catalytic subunit is post-translationally modified at its C-terminus 
with an isoprenyl group that confers its ability to bind to the disk membrane [for review, 
see (Cote, 2002)].
In bovine rod photoreceptor cells, a fraction o f the total PDE is found in a soluble 
form (Gillespie et al., 1989; Florio et al., 1996), and co-purifies with a 17 kDa protein 
that was named the 5 subunit o f PDE. PDE derived from cone photoreceptors also binds 
8 and is not membrane-associated (Gillespie and Beavo, 1988). The bovine 8 protein is 
highly conserved among mammals (99% sequence identity), and homologous proteins 
are found in C. elegans (65% identity) and D. melanogaster (62% identity) (Florio et al., 
1996; Li et al., 1998; Lorenz et al., 1998; Adams et al., 2000). Interestingly, while the 8 
protein is highly expressed in the retina, it is also found in many other tissues that do not 
express photoreceptor PDE (Florio et al., 1996; Lorenz et al., 1998; Marzesco et al.,
1998; Wang et al., 1999). Furthermore, 8 can specifically interact with other proteins 
unrelated to known phototransduction proteins, such as Rabl3 (Marzesco et al., 1998), 
the retinitis pigmentosa GTPase regulator (Linari et al., 1999b), and the Arf-like protein 
Arl3 (Linari et al., 1999a).
Biochemical studies have shown that exogenous 8 can bind to bovine rod PDE 
with high affinity, and cause release o f PDE from the disk membrane (Florio et al.,
1996). This solubilization of PDE correlates with a decrease in the ability o f transducin to 
activate PDE (Cook et al., 2001). The primary site o f interaction o f  8 with PDE is with 
the prenylated, methylated C-terminus o f the catalytic subunits (Cook et al., 2000). It has 
been proposed that the ability of 8 to solubilize disk membrane-associated PDE in vitro
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may be physiologically important as a desensitization mechanism during light adaptation 
(Cook et al., 2001).
To date, all studies o f the 5 protein’s interaction with photoreceptor PDE have 
been carried out using light-exposed, frozen bovine retinas from which ROS were 
isolated. Thus, the light history, degree o f  ROS purity, and extent of loss o f  ROS soluble 
proteins is difficult to control. To address the physiological role o f 8 in regulating PDE 
during phototransduction, we focused on amphibian ROS for several reasons: (1) ability 
to control illumination conditions (diumal light-dark cycle, dark versus light-adapted 
conditions); (2) ease of purification of osmotically intact frog ROS retaining the full 
complement o f soluble and membrane proteins (Cote et al., 1984; Biembaum and 
Bownds, 1985; Hamm and Bownds, 1986), and; (3) ability to correlate biochemical 
measurements with extensive electrophysiological data in the literature.
In this paper, we demonstrate that the frog 17 kDa homologue to the bovine 8 
protein is expressed in frog retina, can bind to PDE, and releases it from the membrane in 
vitro. PDE solubilization by recombinant frog 8 is shown to directly correlate with 
uncoupling o f transducin activation of PDE. 8 also has a significant effect on cGMP 
binding to the noncatalytic sites of PDE. However, quantitative analysis o f the 
stoichiometry and localization of 8 in retina and in isolated ROS demonstrates that there 
is insufficient 8 to significantly affect the subcellular localization o f PDE. Other 8- 
immunoreactive proteins are present in retinal extracts and in purified ROS. A 36 kDa, 8- 
immunoreactive protein that is released from disk membranes along with PDE was found 
to not interact with PDE with high affinity. These results cast doubt on the ability of 8 to 
regulate PDE during visual transduction.
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Experimental Procedure
Materials- Frogs (Rana catesbeiana) were obtained from Niles Biologicals, and 
maintained on a 12 h dark-light cycle for two weeks before use in experiments (Cote, 
2000). Frozen bovine retinas were obtained from W.L. Lawson, and Ficoll-purified 
bovine ROS from freshly isolated retinas (Schnetkamp, 1981) were a kind gift o f Dr. Paul 
Schnetkamp (University of Calgary). [3H]cGMP was from PerkinElmer Life Sciences. 
Membranes for filter binding assays and the polyvinylidene fluoride (PVDF) for 
immunoblotting were obtained from Millipore. Reagents and substrates for 
immunoblotting were from Pierce or from Bio-Rad. All other chemicals were obtained 
from Sigma. Bovine GST-8 expression plasmid was a kind gift from Drs. Terry Cook 
and Joe Beavo (University of Washington).
Cloning and expression o f  frog 5- A frog (R. pipiens) retinal cDNA library was 
prepared as described elsewhere (Li and Baehr, 1998). Frog 8 was cloned by screening 
the cDNA library using bovine 8 as a probe. The resulting clone, fpdedl, contained a 
2.7-kb cDNA insert in pBluescript SK. The 450 base pair coding region o f  8 was PCR- 
amplified with primers 5 ’-GGATCCATGTCTAGTAATGAGCGA and 5 ’- 
GAATTCTCAAACATAAAACAGCCTG, containing Bam HI and EcoRl restriction 
sites. The resulting PCR product was inserted into the TOPO cloning vector and then 
transferred into the pGEX-KG expression plasmid. DNA sequencing o f  both strands 
confirmed the coding region to contain the authentic nucleotide sequence. The cloning 
o f frog 8 was done by Ning Li and Wolfgang Baehr, University o f Utah Health Center.
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The pGEX-KG construct was transformed into the E.coli strain BL21 DE3. 
Overnight cultures were diluted 1:20 and grown at 37° until the OD600 reached 0.7, at 
which point 1 mM isopropyl-(3-D-thiogalactopyranoside was added to induce protein 
expression. Growth continued for 1 hour at 37°. Cells were pelleted by centrifugation, 
washed, and the resuspended cell pellet was sonicated. Centrifugation removed the 
membranes, and the extracted proteins were applied to a glutathione-agarose column, 
closely following established procedures. Bound GST-5 was eluted, concentrated by 
ultrafiltration (Millipore BioMax 15K MWCO filter) then cleaved with thrombin (4 hours 
at 37°). The thrombin was removed with the Thrombin Cleavage Capture Kit (Novagen). 
The 5 was purified from GST by passage over a  glutathione-agarose column, and the 
recombinant frog 5 was concentrated by ultrafiltration (Millipore BioMax 5K MWCO 
filter). The concentration of 5 was determined with a colorimetric protein assay (Smith et 
al., 1985) and agreed with spectrometric measurements at 280 nm. The purity of the 
protein was >95%, as judged by SDS-PAGE.
Preparation o f  Rod Outer Segments (ROS)- Osmotically intact frog ROS were 
purified on a discontinuous Percoll gradient exactly as described (Cote, 2000). Purified 
ROS were homogenized in a pseudointracellular medium [LIM: 77 mM KC1, 35 mM 
NaCl, 2.0 mM MgCl2, 1.0 mM CaCl2, 1 mM EGTA, 10 mM HEPES (pH 7.5), 2 mM 
dithiothreitol, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 1 pM leupeptin, and 1 
pM pepstatin]. Endogenous nucleotides were depleted by incubation of ROS 
homogenates in the dark at room temperature for 30 minutes. For ROS isolated from 
dark-adapted frogs, the rhodopsin concentration was determined using difference
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spectroscopy (Bownds et al., 1971). The concentration o f PDE in ROS from both dark- 
adapted and light-adapted frogs was determined by a cGMP filter binding assay (see 
below).
Bovine ROS from frozen retinas were purified in the dark on a discontinuous 
sucrose gradient as previously described (McDowell, 1993). In some cases, the sucrose- 
purified ROS were removed from the sucrose gradient, resuspended in Ringers, and then 
loaded on a discontinuous Percoll gradient for further purification. ROS were 
homogenized in LIM at 4° in the dark. The concentration o f rhodopsin was determined 
by difference spectroscopy. PDE concentration was determined by measuring the 
maximum cGMP hydrolysis o f the PDE upon limited trypsin proteolysis (see below).
Subcellular fractionation o f ROS homogenates was performed by centrifugation 
for 3 minutes at 110,000 x gaV at room temperature using a Beckman Airfuge. The 
integral membrane protein, rhodopsin, was present in the supernatant at undetectable 
levels and >95% o f the rhodopsin was recovered in the membrane pellet under this 
condition.
To hypotonically extract PDE, ROS homogenates were spun down to remove 
soluble proteins. The ROS membranes were washed in hypotonic buffer (5 mM Tris, 0.5 
mM EDTA, 1 mM dithiothreitol) supplemented with 10 mM M gCh to reduce the amount 
o f peripheral membrane proteins. Three consecutive washes o f  the membranes with 
hypotonic buffer lacking MgCk were done to extract the PDE from the membranes. The 
first wash included a 10 minute incubation on ice before centrifugation. To extract PDE 
using CHAPS detergent, ROS membranes were prepared as above, and then the 
membrane pellet was resuspended in LIM containing CHAPS (final concentration o f  10
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mM). This sample was incubated on ice for 10 minutes before centrifugation. Two more 
extractions o f the membranes with 10 mM CHAPS were performed and the detergent- 
solubilized PDE pooled.
Immunoblot analysis o f  the Sprotein in frog  ROS- Samples for immunoblot 
analysis were added to electrophoresis sample buffer, followed by SDS-PAGE on a 12% 
polyacrylamide gel. Proteins were transferred onto Immobilon-PSQ polyvinylidene 
fluoride or nitrocellulose membranes. The membrane was blocked with 1% bovine 
serum albumin in TTBS (20 mM Tris pH 7.6, 137 mM NaCl, 0.5% Tween 20) prior to 
incubation with anti-5 antibodies. Anti-5 antibodies were generated in rabbits using the 
following immunogens: FL antibody: full-length bovine recombinant 5; FD antibody: a 
synthetic peptide consisting o f a.a. 4-12 o f the frog 5 sequence conjugated to KLH; BD 
antibody: a synthetic peptide consisting o f a.a. 41-52 of the bovine 5 sequence. The 
antibodies were affinity purified over a 5-Sepharose column, or by peptide-coupled 
beads. Antibodies to PDE catalytic subunits (NC; 1:10,000 dilution), and transducin a  
subunit (Santa Cruz Biotech., 1:10,000 dilution) were also used. Antibody binding was 
detected using a goat anti-rabbit secondary antibody coupled to horseradish peroxidase 
(1:5000 dilution), followed by incubation o f the membrane with peroxidase substrate 
(Pierce SuperSignal West Pico Chemiluminescent Light). For quantitative analysis o f the 
5 protein in frog and bovine ROS, a standard curve of known concentrations o f 
recombinant frog or bovine 5 was run on the same gel as the sample of purified ROS. 
Quantitation o f immunoreactive bands was performed with the image analysis program, 
Quantiscan (Biosoft).
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Immunocytochemistry- Fresh bovine eyes were obtained from the slaughterhouse. 
The eyes were hemi-sected and the back portion o f the eyecup was gently everted to 
expose the retina. This was immersed in 4% paraformaldehyde in 0.1 M phosphate 
buffer (pH 7.4). The eye was washed in ice-cold phosphate buffer and soaked in 30% 
buffered sucrose. Cryosectioning o f the eye was performed, and the sections were 
exposed to primary antibody (8, FL). The sections were washed and a secondary 
antibody conjugated to a fluorescent marker was added. Digital images were acquired by 
a confocal microscope. Images were cropped, enlarged, and contrast-enhanced with 
Adobe Photoshop (Adobe Systems, San Jose, CA). Immunocytochemistry was 
performed by Dr. N. Vardi, University of Pennsylvania.
cGMP binding and PDE activity assays- The frog PDE concentration was 
routinely determined by quantitating [3H]cGMP binding to PDE under standard 
conditions where it has been established that 2 cGMP bind per PDE holoenzyme (Norton 
et al., 2000). In brief, PDE-containing samples were incubated for 10 min at room 
temperature with 1 pM [3H]cGMP, 200 pM zaprinast, and a 2-fold molar excess o f  Py. 
Samples were filtered on pre-wet nitrocellulose filters, immediately followed by three 1- 
ml washes with ice cold LIM (Cote, 2000).
The rate o f  transducin-activated PDE hydrolysis was measured by a coupled- 
enzyme phosphate release assay (Cote, 2000). GTPyS (equal in concentration to the 
amount o f rhodopsin) was added to the PDE sample for 1 minute prior to the addition o f 
10 mM cGMP. For each experiment, rate measurements were obtained from at least 3 
individual time points, during which time less than 30% of the substrate was consumed.
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Measurements o f the activity were made in the following buffer: 100 raM Tris (pH 7.5), 
10 mM MgCb, 0.5 mM EDTA, 2 mM dithiothreitol, and 0.5 mg/ml bovine serum 
albumin. This PDE enzyme assay was also used to determine the PDE content o f various 
bovine ROS samples. In this instance, the bovine PDE was treated with trypsin to fully 
activate the enzyme (kcat = 5600 s '1) to estimate the enzyme concentration (Mou et al.,
1999).
Co-precipitation o f  PDE and S  - Four different antibodies were tested for their 
ability to immunoprecipitate 5 or 5-like proteins. The FD, BD, and FL anti-5 antibodies 
were coupled to protein A beads prior to use. The ROS1 PDE antibody (Hurwitz et al., 
1984) was coupled to Sulfolink beads (5 mg/ml). For immunoprecipitation, solubilized 
PDE was added to the antibody-coupled beads and incubated for 1-2 h at 4°. The beads 
were then washed with TMN buffer (10 mM Tris pH 7.5, 1 mM MgCk, 300 mM NaCl, 1 
mM dithiothreitol) three times, followed by elution of the bound proteins by boiling in 
2X SDS-PAGE sample buffer. To minimize the elution of heavy or light antibody chains 
from the beads, 0.1 M glycine buffer pH 3 was also used to elute proteins from the beads.
To examine the binding of recombinant 5 to PDE by immunoprecipitation, 5 was 
added to ROS and incubated overnight to release PDE from the membrane. The 
supernatant was collected and incubated with ROS1 coupled to Sulfolink beads for at 
least 2 hours at 4° prior to washing and eluting the proteins bound to the beads. 
Alternatively, PDE binding to recombinant GST-5 and its release from its membrane- 
attached state was assayed by using glutathione-agarose beads to pull down GST-5 and 
any proteins to which it was bound.
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Gel filtration chromatography o f  hypotonic extracts o ffrog  ROS- Hypotonically 
extracted PDE was chromatographed on a Superdex 200 (Amersham Pharmacia Biotech) 
column equilibrated in: 5 mM Tris (pH 8), 0.5 mM EDTA, 10 mM NaCl, 1 mM 
dithiothrietol, 0.2 mM Pefabloc. 0.3 ml fractions were collected. PDE elution was 
determined by an activity assay. The protein-containing fractions were precipitated with 
3.5% TCA, incubated for 5 minutes at room temperature, and then centrifuged. The 
pellets were resuspended in Laemmli gel sample buffer and heated to 80° for 10 minutes. 
The proteins in the fractions were examined by western analysis. A standard curve for 
the molecular weight calibration of the Superdex 200 was done using the Molecular 
Weight Marker Kit for gel filtration chromatography range 29,000-700,000 (Sigma).
Results and Discussion
Frog retina contains a 17 kDa protein homologous to the bovine rod 
photoreceptor 5 protein. To identify the frog retinal homologue o f the mammalian 17 
kDa 6 protein, a Rana pipiens retinal cDNA library was screened using the bovine 5 
nucleotide sequence as a probe. A clone containing the complete coding region (450 
base-pairs) o f frog 8 was identified and sequenced. The deduced amino acid sequence for 
frog 8 represents a protein o f  149 amino acids, one shorter than mammalian 8 (Figure 
3.1). The amino acid sequence of frog 8 is 80% identical (90% similarity) to known 
mammalian 8 sequences, indicating that this protein is highly conserved through 
vertebrate evolution. Substantial sequence homology (60-70% sequence
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CG9296_DRCME------------------ IQKGPQINYMILROADSGaiWQENKDFSAPDQEH-----------------------EARVPVKXLDMRA------- VSREINFSTI-ESMENF 7 5
u n c l! 9 /R G 4  ---------------- NIYNIDFiRFKIRDLDSGrVLFEIAKPPVSERLPINNRDADPNRGRFVRYQFrPAFLRLRT VGATVEFTVGDKFVNN 70
GDIR_HUMAN ---------------- NVWTGL7LVCSS APGPLELDLTGDLESFK KQSFVLKEGVEYRIKISFRVNREIVSaf 1 2 6
M a j o r i t y  RLEQKVYFyGQCLEEWrFEPGFVXPNSTNTWQSLIEAAPESQMMPASVL-T G y V IIE r— KFFD0DLLVS7SRVRLFYV-----------
80 90 100  1 10  1 20  I  1 3 B  140
CNRD_FROG RLEQKVYFKGCJCLEEWSEEPGFVMPtJSVNTWQSMIEAAPESCHMPANVL-TGNVIIET— KFYDADLLVSTSRVRLEYV 149
CNRD_BOVIN RLEQKVYPKGOCLEEWFFEPGEVI?NSTNTWQSLIEAAPESQMMPASVL-TGNVIIET~KFFDDDLLVSTSRVRI.FYV 1 50
CNRD~HUMW; RLEQKVYFKGQCLEEHFTEEGr/IPNSTNTO<3SLIEAAPES®«CASVX.-TQfVIIET—  KFFDDDLLVSTSRVFlLrYV 1 5 b
CNRD_CANEA RLEQKVYPKGQCLSEWFFEFGFVIPKSTNTWQSLIEAAPESQMMPASVX-TGNVXIET— KETDDDLLVSTSRVRLPYV 1 50
CNRD_MOUSE RLEQKVYfKGQCLEEWFFEFGFVIPNSTNTWQSLXEAAPESQMMPASVL-TGNVIIET— KFFDODLLVSTSKVRLPYV 1 5b
CNRD_CKICK RLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESCMMSANVL-TS4VTIE7— KFfODOLLVSTSRVRLPYV 1 5 0
CNRD_CIONA RLEQRVLFKGKCLEEWFFEFGFVIPDSTtrrWQSVIEAAPASQKMPASVL-StaJWICT—QFYDDDVLVSTSRVRIYYV 1 40
YK91~CA£EL RLEQRVYLKGTIIEEWYEDFGFVIPDSTNTBQNMXEAAPESCMrPPSVL-SGNWVET— LFYDGDLLVSTSRVRLYYD 1 59
CG 92 9 6 _  DROME RLDQKVLFKGRIMEEWFFEMGPVGASTTNTWQSTIEAAPESQMMPAKVL-NGNVTICrr— SPYDNETLITKSWRLYYI 1 5 1
u n c !1 9 /R G 4  PRMXERHYFRDQLLKSFDrEFGPCIPSSKNTCEKIYEFPPLSEDLISEMIRHPYETQSDSrYFVDNKLVMHNKADYSYS 159
GDIR_HDMAN KYIQHTYRKGVKIDKTDYMVGSYGPRAEE---------- YEFX.TPVEEAPKC24LARGSYSIKS— RFTDDDKTDHLSWEWNLTIKKDWKD 204
Figure 3.1. The frog 5 sequence is homologous to other 5 proteins. The deduced amino 
acid sequence o f frog 5 was obtained from the nucleotide sequence (deposition Genbank 
AY044177). Multiple sequence alignment with known 5 and S-Iike proteins was 
performed using CLUSTALW (default options). The following 5 sequences were 
aligned for evaluation of the conserved amino acid residues: human 8, Q43924; mouse 8, 
AAC40094; dog 8, AAD54058; bovine 8, Q95142; C. elegans 8, Q18268; D. 
melanogaster 8, AC015134; chicken 8, derived from EST AL588430, and Ciona 
intestinalis 8, AB079881. The consensus sequence for unci 19/RG4 was obtained from 
analysis o f 8 sequences currently available in GenBank. The RhoGDI sequence is 
GDIR_HUMAN, and the residues forming the prenyl binding pocket (Hoffinan et al.,
2000) are indicated with *.
identity) o f frog 8 with three invertebrate orthologues o f 8 is also evident when these 
sequences are aligned (Figure 3.1). Phylogenetic analysis indicates that sequence 
divergence of 8 agrees with the order of general evolutionary divergence, where 
amphibians diverged earlier in time than mammals and birds.
Other proteins closely related to 8 have been identified, namely unci 19/RG4 
(Higashide et al., 1996) and RhoGDI (Nancy et al., 2002). Based on comparisons o f  the 
predicted secondary structure and the pattern o f hydrophobic residues in the three
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proteins, a structural homology model based on the isoprenyl binding domain of RhoGDI 
has been proposed (Nancy et al., 2002). This prenyl binding pocket consists of all but the 
extreme N-terminus o f 5, whereas the larger unci 19/RG4 and RhoGDI proteins 
incorporate this domain in their C-terminal region. Figure 3.1 also include the consensus 
sequence for unci 19/RG4 derived from alignment o f  8 sequences available in GenBank, 
as well as the sequence for human RhoGDI.
Several residues o f the RhoGDI prenyl binding pocket are conserved in the 6 
protein sequence. Thus, secondary structural information o f the 8 protein can be inferred 
by comparison to the RhoGDI crystal structure analysis (Hoffinan et al., 2000). It was 
proposed that the 8 protein folds similar to the C-terminal immunoglobulin-like domain 
o f RhoGDI, creating a hydrophobic pocket. In RhoGDI, this pocket is where the 
geranylgeranyl moiety o f the small GDI protein inserts. The existence o f this pocket in 
the 8 protein is consistent with several results (Marzesco et al., 1998; Linari et al., 1999b; 
Linari et al., 1999b), including the ability o f 8 to release membrane-bound PDE (Florio et 
al., 1996). However, 8 interaction with non-prenylated proteins such as the retinitis 
pigmentosa GTPase regulator, RPGR (Linari et al., 1999b) and the Arf-like protein Arl3 
(Linari et al., 1999a) that are localized to various tissues, may occur through a region 
(amino acids 44-52) that is not conserved in RhoGDI (Nancy et al., 2002).
The majority o f  the 8 sequence is involved in forming the isoprenyl binding 
domain. Unci 19/RG4 is a 25 kDa protein that also contains sequence similarity in the 
isoprenyl binding domain. Thus, these three proteins RhoGDI, Unci 19/RG4, and 8 may 
form a family o f proteins whose role includes membrane trafficking o f proteins through
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interactions at this isoprenyl binding domain. The short sequence o f 5 suggests that it 
may be the basic prototype for this family.
Recombinant fro g  5  binds to and releases fro g  PDE from  ROS membranes. To 
test whether frog 5 retains the biological activity reported for the mammalian homologue, 
we expressed recombinant frog 8 in E. coli as a GST-fiision protein. Purification o f the 
fusion protein by glutathione-agarose affinity chromatography yielded 4 mg of GST-5 
per liter o f bacterial culture. The apparent molecular weight o f the GST-5 was 43 kDa, 
running as a single band on SDS-PAGE. After cleavage o f the GST portion with 
thrombin and re-purification, the resulting 17 kDa 5 was >95% pure, and migrated 
identically to native frog 8 on SDS-PAGE.
To test whether frog 5 retained the ability to solubilize membrane-bound PDE, we 
added increasing amounts o f recombinant frog 5 to ROS homogenates. The soluble 
proteins were separated from the membranes by centrifugation. In contrast to bovine 
ROS where 20-30% o f the total PDE is found in the soluble fraction (Gillespie et al., 
1989), purified frog ROS have essentially no PDE in the soluble fraction (1.0 %± 0.2 %; 
n = 5). Addition o f increasing amounts of frog 5 can release up to 100% of the PDE from 
ROS membranes in a dose-dependent maimer (Figure 3.2). The effectiveness with which 
frog 8 releases frog PDE from the disk membrane is comparable to previously reported 
values for bovine PDE solubilization (Florio et al., 1996). In both cases, a 4-6-fold excess 
o f  5 relative to PDE is needed to solubilize 50% of the total enzyme. The IC50 o f frog
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Figure 3.2. Frog 5 releases PDE from ROS membranes. Frog ROS homogenates (20-40 
nM PDE) were incubated with increasing amounts o f recombinant frog 6 overnight at 4°. 
Samples were centrifuged to separate solubilized (•) from membrane-associated (o) PDE. 
The amount of PDE in each sample was determined by the cGMP binding stoichiometry 
(see Methods). Data are mean ± S.E.M. for 6 separate experiments.
PDE release from ROS membranes is 128 ±11 nM recombinant frog 5 (20-40 nM PDE, 
4°). The time needed for 5 to exert its solubilizing effect on membrane-bound PDE is 
slow: only one-third o f the total PDE is released after 5 h incubation of 5 with ROS at 
4°, compared to 100% release after 24 h. The slow release o f membrane-associated PDE 
by 5 is not explained by a slow incorporation of 5 into ROS membranes, since 
immunoblot analysis shows no increase in 17 kDa 5-immunoreactivity in ROS 
membranes following addition of exogenous 5. Thus, recombinant 5 does not bind to 
ROS membranes but rather slowly exerts a direct effect on PDE to solubilize this 
enzyme.
To test whether recombinant 8 remains bound to PDE following its release from 
the disk membranes, 8-solubilized PDE was immunoprecipitated with the PDE catalytic
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Figure 3.3. Frog 5 binds to PDE upon releasing it from the disk membranes. Frog ROS 
homogenates were incubated with either recombinant frog 8 or GST-5 overnight. PDE 
that was solubilized by treatment with 8 8 per PDE was immunoprecipitated with ROS1- 
agarose beads, while PDE incubated with 30 GST-5 per PDE was pulled down with 
glutathione-agarose beads. The supernatants and pellets were analyzed after a brief spin. 
The immunoblot was probed with antibodies to 5 (FD) and PDE (NC).
subunit antibody, ROS 1 (Hurwitz et al., 1985). All o f  the solubilized PDE was pulled 
down with the PDE antibody, along with recombinant 5 (Figure 3.3). In a sim ilar 
experiment, we incubated frog ROS membranes with recombinant GST-5, which also 
solubilizes PDE effectively. After adding glutathione-agarose beads to the soluble PDE, 
we were able to co-precipitate PDE bound to the GST-5 (Figure 3.3). Thus, 8 does not 
act catalytically to release PDE from the membrane-associated state, but rather remains in 
a complex with PDE following solubilization.
Effects o f  Son  cGMP binding and transducin activation o f  fro g  PDE. Membrane- 
associated bovine PDE contains two high affinity cGMP binding sites in its GAF 
domains, but one o f these sites does not exchange its bound cGMP with free cGMP.
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Addition o f exogenous 8 to bovine rod PDE converts this nonexchangeable cGMP 
binding site to an exchangeable site, but the overall binding affinity for cGMP is 
unaltered by 8 binding (Mou et al., 1999). In comparison, frog PDE also has two high- 
affinity noncatalytic cGMP binding sites, but both o f  them readily exchange bound 
cGMP (Cote et al., 1994). To examine the effects o f  8 on frog PDE GAF domains, 
binding o f 1 pM [3H]cGMP was measured as a function o f the amount o f 5 added. No 
increase in the exchange rate of bound cGMP was observed following 8 addition. 
However, addition o f recombinant 8 decreased by up to 25% the maximum binding o f 
cGMP to the noncatalytic sites o f frog PDE (data not shown). An 8-fold excess o f 8 
relative to PDE was needed to observe this 25% decrease in cGMP binding, consistent 
with the efficacy o f 8 to solubilize frog PDE. Because o f the positive cooperativity 
between cGMP binding and the Py subunit interaction with PDE, we next examined 
whether 8 could influence Py affinity for PDE. Addition of increasing amounts o f 8 to 
nonactivated PDE had minor effects on the basal rate o f PDE, suggesting little effect o f 8 
on the interaction o f y with the catalytic sites. However, the ability o f 8 to affect cGMP 
binding to frog and bovine PDE suggests that the mechanism o f 8 binding to the 
isoprenylated C-terminus induces an allosteric change in the catalytic subunit that is 
reflected in a local conformational change in the GAF domains. This significance o f this 
effect is not clear at present.
A proposed role for 8 in phototransduction is to release PDE from the membrane, 
preventing its association with transducin, thereby causing a decrease in the maximum 
transducin activation o f  PDE (Cook et al., 2001). To test the relevance o f this hypothesis 
for frog ROS, nonactivated frog ROS homogenates were incubated overnight with
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recombinant 8, and then assayed for the maximal PDE activation by transducin. A 
reduction in the maximum transducin-activated PDE rate correlated with the release of 
PDE from the membrane into the supernatant (Figure 3.4). We found that there was a 
70% decrease in the maximum transducin-activated PDE rate with the addition o f a large 
molar excess o f 5. The IC50 for suppression of transducin activation o f PDE was similar 
to the IC50 for solubilization o f PDE (Figure 3.4). This uncoupling o f transducin
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Figure 3.4. 5 decreases the ability of transducin to fully activate PDE. Light-exposed 
ROS homogenates (40 nM PDE) were incubated with increasing amounts o f 
recombinant frog 5 overnight at 4°. GTPyS (12.8 pM) was added to one portion to 
determine the maximum extent o f PDE activation (o). The remainder (lacking GTPyS) 
was centrifuged to measure the extent of PDE solubilization (•). Western analysis o f the 
nonactivated PDE samples shows that while the PDE is solubilized from the membranes 
by recombinant 5, Toe remains membrane-bound. The immunoblot was probed with a 
mixture o f the PDE (NC) and transducin (Ta) antibodies. Graph shows the average ± 
SEM for 3 separate experiments.
70
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
activation of PDE by 5 is not accompanied by solubilization o f  the transducin a  subunit, 
since immunoblots show no release o f T a  upon 5 addition (Figure 3.4), in agreement 
with previous results (Cook et al., 2001). We conclude that in order for there to be 
efficient activation o f PDE, PDE must be attached to the membrane in proximity with the 
membrane-associated transducin. These in vitro results are consistent with the hypothesis 
that 5 could desensitize the phototransduction pathway by regulating the subcellular 
localization o f PDE.
Sub-stoichiometric levels o f  the 5protein are found  in fro g  ROS. In order for 5 to 
solubilize the entire pool of PDE in the rod outer segment, 5 must be present in 
stoichiometric amounts relative to PDE. This is because 5 remains in a complex with 
PDE following solubilization (Figure 3.3). To determine the concentration of 5 in ROS, 
we performed immunoblot analysis using anti-6 antibodies. When frog retinal 
homogenates, crude ROS preparations, or Percoll-purified ROS were separated by SDS- 
PAGE, several 6-immunoreactive bands were detected on immunoblots, including the 
expected 6 band at 17 kDa (Figure 3.5). In retinal homogenates and crude ROS, the most 
abundant 5-immunoreactivity was seen with proteins o f 17 and 33 kDa, with additional 
bands o f lower intensity. However, purification of frog ROS on a Percoll gradient to 
obtain osmotically intact outer segments removes the majority o f  the 17 kDa 
immunoreactivity. This suggests that most of the 8-immunoreactivity seen in retinal 
homogenates and crude ROS is of non-ROS origin.
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Figure 3.5. Little 5 co-purifies with intact frog ROS. Frog ROS were purified on a 
Percoll gradient to examine the localization of the 17 kDa 5 protein. Samples (1 pmol 
PDE per lane) tested were: R, retinal homogenate; C: crude ROS; H, purified ROS 
homogenate. Soluble proteins (IS) were separated from ROS membranes (IM) by high­
speed centrifugation in the light. The membranes were resuspended with 10 mM MgCfe 
and re-centrifuged to obtain a supernatant (MS) portion. PDE was released by a 
magnesium-free hypotonic solution (see Methods) and centrifuged to obtain a supernatant 
(HS) and membrane (HM) fraction. The affinity purified FL 5 antibody was used for the 
western analysis.
To quantify the amount of 5 present in ROS, we compared the amount o f  17 kDa 
immunoreactivity in ROS samples to known amounts o f recombinant, purified frog 5 
applied to the same gel. We found only 0.03 ± 0.005 mol 5 per mol PDE in purified frog 
ROS (Table 3.1). In contrast, the unpurified retinal homogenate contains 0.62 ± 0.05 mol 
5 per mol PDE. The small amount o f 5 detected in ROS suggests that most o f  the 17 kDa 
protein in the frog retina is expressed in other cells of the retina or in a portion of the 
photoreceptor cell other than its outer segment.
Because >95% of PDE from frog ROS is membrane-bound (Norton et al., 2000), 
we next determined the subcellular localization of 5 by centrifugation. Fractionation of 
ROS homogenates in an isotonic medium demonstrates that most o f the 17 kDa 5 protein 
is soluble (Figure 3.5, lane IS). The fact that most 5 is soluble, while PDE is membrane-
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associated, indicates that the low levels of 8 present in intact frog ROS are not sufficient 
to solubilize a significant portion of the PDE. Other 5-immunoreactive bands detected in 
ROS homogenates were found to localize to either the isotonic soluble or membrane 
fractions. A small amount of the 5 protein remains membrane-associated at all times 
including when PDE is extracted with hypotonic buffer or 10 mM CHAPS. When large 
amounts o f the hypotonic extract are examined by western analysis, 36 kDa and 90 kDa 
8-immunoreactive proteins are seen (Figure 3.7B). However, a portion o f each of these 
proteins is not extracted and can be found in the membrane fraction following hypotonic 
extraction.
We considered the possibility that different expression levels or sub-cellular 
localization o f S might result from the light history of the retinas prior to isolation. No 
differences were observed in either the 8 content o f frog ROS or its subcellular 
localization when comparing dark-adapted versus illuminated conditions or subjective 
day versus subjective night conditions (data not shown).
These results with frog ROS led us to re-evaluate whether the concentration o f  5 
in bovine ROS is similar to our results reported above. Quantitative immunoblot analysis 
using recombinant bovine 8 standards on the same gel as bovine ROS samples reveal low 
levels o f 8 in sucrose-purified bovine ROS from frozen retinas (Table 3.1; 0.05 ± 0.001 
mol 8 per mol PDE; n = 3). Bovine retinal homogenates contain ~10 fold greater amounts 
of 8 (0.44 ± 0.044 mol 8 per mol PDE; n = 8), suggesting a non-ROS origin for much o f 
the 17 kDa 8 protein in both amphibian and mammalian retinas. Overall, the number and 
relative intensity o f 8-immunoreactive bands in bovine ROS are qualitatively similar to
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Table 3.1. Quantitation o f 5 in ROS. The amount o f 5 in purified bovine and frog ROS 
was determined by western analysis. ROS samples were loaded on SDS-PAGE along 
with known amounts o f 6. The samples were transferred to PVDF membrane for 
immunoblot analysis (FL antibody 1:20,000). The amount o f  8 in each ROS sample was 
determined by Quantiscan. Data represents mean ± S. E. M. for n determinations. The 
concentration o f PDE was determined by cGMP binding for frog PDE, and by activity 
measurements for bovine PDE.
those in frog ROS. (Unlike Figure 1A o f Cook et al. (Cook et al., 2000), we did not 
observe these bands to be artifacts associated with the secondary antibody.)
The amount o f 5 found in our purified bovine ROS from frozen bovine retinas 
was less than expected based on previously published results (Cook et al., 2000). To 
examine whether the results we obtained were due to the fact that the retina’s were frozen 
prior to purification o f the ROS, we obtained sucrose- and Ficoll-purified ROS from fresh 
bovine retinas (a kind gift o f Dr. Paul Schnetkamp, University o f  Calgary) (Schnetkamp, 
1981). Table 3.1 shows that the freshly isolated bovine ROS contained slightly more 8 
than found in the frozen ROS samples, possibly due to disruption o f  photoreceptor cell 
integrity upon freezing and thawing the retinas. However, the overall amount of 8 in 
fresh bovine ROS is much lower than the amount of PDE present, consistent with our
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original observations in both frog and bovine ROS. The subcellular location of the 5 in 
fresh bovine ROS is also similar to the data obtained from frog ROS. The main 
difference between the two species examined is the amount of soluble PDE from each 
preparation. The results obtained here suggest that the amount o f membrane association 
is not due to the 5 protein, since the ratio between 5 and PDE in both species are similar 
and the effect seen by exogenous 5 also is consistent. It is possible that the PDE in 
bovine ROS contain a higher level o f carboxymethylation than that in frog ROS. Cook et 
al. (2000), show that PDE that is released by the 8 protein contains a higher level o f C- 
terminal carboxymethylation at the site of prenylation.
Localization o f  8 in the retina by immunocytochemistry. Previous research 
showed the localization of the 8 protein in bovine retina exclusively to the rod outer 
segment portion o f  the retina (Florio et al., 1996). However, the antibody that was used 
for the immunocytochemistry results was not the same one presented in the paper 
showing 8 localization on immunoblots. Thus, it is possible that the 
immunocytochemistry results reflect some 8-im m unoreac tiv e  proteins other than 8. The 
relative lack o f 8 found in the outer segment of the frog and bovine retina convinced us to 
reexamine the localization o f the 8 protein in the retina.
Figure 3.6A shows the results of immunocytochemistry o f a bovine retina with 
the FL 8 antibody (red) used throughout this chapter for immunoblot analysis and double 
labeling with an antibody raised to red/green opsin antibody to which detects cone cells 
(COS; green). The scattered immunoreactivity in the outer segment layer (OS) o f the 
retina is consistent with cone cells than the more abundant rod cells. The yellow
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Figure 3.6. Localization o f the 8 protein in bovine retina. Fresh bovine eyes were hemi- 
sected, everted and fixed in 4% paraformaldehyde. The eyes were washed in phosphate 
buffer, and incubated in buffered sucrose. Cryosections were performed, and the sections 
treated with primary antibody. Panel A was probed with FL (5 antibody) and COS (cone 
opsin antibody). Panel B was probed with COS. The secondary antibody used was 
conjugated to a fluorescent marker. Pictures were taken on a confocal microscope. The 
layers o f the retina are: outer segments (OS), inner segments (ISO, outer nuclear layer 
(ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner pleform layer (IPL), 
ganglion cell layer (GCL), and the neural fiber layer (NFL). This work was performed 
by N. Vardi, University of Pennsylvania.
fluorescence shows cells that contain both cone opsin and 8 protein. Figure 3.6B shows 
immunoreactivity of the cone cells alone by probing with COS. Interestingly, there are 
three other cell layers that show 8 immunoreactivity(red), the inner segments (IS), inner 
nuclear layer (INL) and ganglion cell layer (GCL). The wide distribution o f 8 in various 
retinal cells is consistent with the quantitative immunoblot analysis we presented above. 
This suggests that the 8 we see in our frog ROS preparations could be a contaminant from 
either cone cells, or possibly the inner segment of rod cells. However, this
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immunocytochemistry is a preliminary experiment and more needs to be done to examine 
8 localization, including controls for nonspecific labeling and co-localization o f 8- 
immunoreactivity with photoreceptor-specific antibodies. Specificity o f the antibody will 
be examined by blocking the retina with recombinant 5 prior to the antibody incubation. 
We also need to repeat the immunocytochemical localization of 5 in the frog retina to 
ensure that the results for the two species are the same.
Co-purification o f  5-immunoreactive proteins with PDE in frog  ROS. There was 
more 5 immunoreactivity seen in higher molecular weight proteins than with the 17 kDa 
band in purified frog ROS (Figure 3.5). We therefore questioned whether PDE was 
interacting with other 5-like proteins present in frog ROS. We started by examining 
whether any 8-immunoreactive proteins co-purified with PDE when it is released from 
the membrane by hypotonic extraction. Treating washed ROS membranes with a 
hypotonic buffer extracts -60%  o f the PDE, but the very small amount of 17 kDa 5 
remains membrane-associated under this condition (Figure 3.5). Detergent extraction of 
washed ROS membranes with 10 mM CHAPS releases 90% of the PDE, but not 8 (data 
not shown). However, a 36 kDa protein which is membrane-bound under isotonic 
conditions can be co-extracted with PDE upon treatment o f ROS membranes with a 
hypotonic buffer (Figure 3.5, HS). Immunoblots with other anti-8 antibodies were 
consistent with the results in Figure 3.5 with the FL 8 antibody.
Due to the co-solubilization o f PDE and the 36 kDa 8-immunoreactive protein 
observed in frog ROS, we sought to determine whether this protein binds to PDE. When
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Figure 3.7. PDE does not associate with the 36 kDa S-immunoreactive protein. Frog 
PDE was hypotonically extracted from purified ROS (HS) and 29 pmol were loaded on a 
gel filtration chromatography column. 0.3 ml fractions were collected and portions 
assayed for PDE activity (panel A). The remainder was concentrated, proteins separated 
by SDS-PAGE, and immunoblots probed with FL antibodies (panel B).
we hypotonically extracted PDE and the 36 kDa protein from ROS membranes, and 
immunoprecipitated PDE with ROS 1-Sulfolink beads, PDE was quantitatively 
precipitated while the 36 kDa protein remained in the supernatant (data not shown). To 
further investigate whether a 8-immunoreactive protein was binding to PDE, gel filtration
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chromatography was performed using hypotonically extracted PDE. The fractions were 
analyzed by a PDE activity assay to determine where the PDE eluted (Figure 3.7). The 
apparent Mr for hypotonically extracted frog PDE on the Superdex 200 column was 410 
kDa. This suggests that either PDE does not behave as a globular protein on the column, 
or that the PDE holoenzyme (Mr 220,000) exists in a complex with other ROS proteins 
under these conditions. The latter possibility is supported by Coomassie staining o f the 
PDE peak revealing additional, unidentified proteins co-eluting with PDE (data not 
shown). Most o f the 36 kDa 8-immunoreactivity eluted at ~60 kDa.
Gel filtration of PDE solubilized from ROS membranes by exogenous 5 showed a 
similar apparent molecular weight to that seen in Figure 3.7. The majority of the 8 and 
PDE co-eluted from the column, demonstrating that the PDE-8 interaction was of 
sufficient affinity to remain in a complex during gel filtration. In contrast, PDE released 
from ROS membranes by trypsin proteolysis had an apparent Mr o f 196 kDa. The failure 
to detect significant binding of 8-immunoreactive proteins by either ROS 1 
immunoprecipitation or gel filtration chromatography makes it unlikely that PDE is 
regulated by binding o f 8 or a 8-like protein to the C-terminal, isoprenylated catalytic 
subunits o f PDE.
Conclusions
The results presented here suggest that 8 is not a subunit o f PDE due to its low 
abundance and lack o f  binding to PDE in rod photoreceptor cells. Preliminary evidence 
from immunocytochemistry suggests that 8 may be localized to cone and other retinal 
cells, but not the rod outer segments. The wide tissue distribution o f the 8 protein
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suggests a more wide-spread role as a prenyl binding protein, possibly directing 
intracellular targeting of prenylated proteins. 5 also interacts with non-prenylated 
proteins (Linari et al., 1999b; Linari et al., 1999a), so additional contact sites besides the 
prenyl binding pocket are likely. The PDZ recognition sequence at its extreme C- 
terminus also presents the possibility o f serving to dock prenylated proteins into signaling 
complexes.
Our comparative analysis of frog and bovine ROS samples suggests that the 
presence and abundance of 5 in amphibian and mammalian retina are similar, consisten 
with the high degree o f conservation o f other phototransduction components. It is likely 
that the designation of the 5 protein as a subunit o f PDE was premature, and if  it has a 
role in visual transduction, it is likely to be limited to cone cells.
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CHAPTER 4
BINDING OF ROD OUTER SEGMENT PROTEINS TO 
PHOSPHODIESTERASE: POTENTIAL ROLES IN REGULATING
VISUAL TRANSDUCTION
Summary
Phosphodiesterase (PDE) is the central enzyme o f visual transduction. Proteins 
such as y, 5 and GARP have all been shown to bind to PDE, and besides the well-studied 
y subunit, other proteins may also serve to regulate the enzyme in vivo. We found that 
the interaction between y and Pa(3 is very strong, such that a fragment o f y remains bound 
to trypsin-proteolyzed frog PDE after dilution and purification by gel filtration 
chromatography. Limited trypsin proteolysis o f the y subunit at 0.02 nM PDE resulted in 
a catalytic rate of 7870 ± 150  mol cGMP/PDE/sec for frog PDE, about twice the 
transducin-activated rate. Due to the fact that proteolysis could cause an increased rate of 
hydrolysis, a method to nonenzymatically remove y was developed. The rate by this 
method was 7000 ±180 mol cGMP/PDE/sec, demonstrating that trypsin did not 
significantly alter the enzymatic properties of PDE during limited proteolysis.
It has been proposed that phosphorylation o f the y subunit can regulate PDE 
during phototransduction. To test this, we developed a method to extract and purify y 
from rod outer segments. Cell homogenates incubated in 30% acetonitrile/0.1% TFA and 
then heated to 75° for 5 minutes were able to release 100% o f  y for subsequent analysis. 
Solid phase purification on a Sep-Pak column eluted the y at 40% acetonitrile/0.1% TFA.
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Besides y, other proteins in ROS bind to PDE. Gel filtration chromatography o f 
solubilized frog PDE showed co-elution of a number of different proteins with PDE, 
suggesting that PDE may exist in a multi-protein signaling complex. Specific proteins 
that eluted in the PDE-containing fractions ran at 74 kDa, 65 kDa, 55 kDa, 50 kDa, and 
43 kDa.
One candidate protein that could serve as a scaffold to form protein complexes 
with PDE is the 5 protein. Co-precipitation o f  ROS extracts with immobilized 8 pulled 
down PDE and several other proteins, providing support for the idea that PDE exists in a 
multi-component signaling complex in ROS. One o f these proteins may also serve as a 
direct target for 5 in ROS, since the large excess of PDE over 8 makes it unlikely that the 
major function o f 8 is to directly regulate PDE.
Introduction
1. Mechanism o f  transducin activation o f  PDE
PDE is a heterotetramer composed of two catalytic subunits, P a  and Pp, as well 
as two identical inhibitory subunits, y. In the dark-adapted state, y maintains PDE 
inactivity by physically blocking the active site (Takemoto et al., 1993; Artemyev et al., 
1998). Upon light exposure, activated transducin (Ta-GTP) binds to y and Pap , pulling y 
away from the catalytic site, allowing cGMP to enter and become hydrolyzed. The 
stoichiometry o f  T a  binding to PDE upon activation is controversial. It was widely 
accepted that there were two binding sites for T a  on PDE (Clerc and Bennett, 1992;
Pages et al., 1993). However, in order to obtain complete activation o f  PDE, a large 
excess o f Ta-GTP must be added for reconstituted systems, or activated for ROS
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membrane experiments (Wensel and Stryer, 1986; Bennett and Clerc, 1989; Malinski and 
Wensel, 1992). This suggests that there could be a heterogeneity in the T a  activation of 
PDE, possibly due to the membrane binding of T a as this is correlated to activation 
(Fung and Nash, 1983; Melia et al., 2000). The large excess o f T a  necessary to obtain 
complete activation has made it difficult to determine both the stoichiometry o f T a  
binding to PDE, as well as the stoichiometry o f T a  required for complete activation o f 
PDE. One possibility is that there is cooperative binding o f two T a to PDE for full 
activation of PDE (Whalen and Bitensky, 1989; Bruckert et al., 1994). It is also possible 
that full activation o f PDE requires only one Ta-GTP and the second PDE catalytic site 
remains inactive. Melia et al. (Melia et al., 2000) showed that complete activation o f 
bovine PDE in reconstituted membranes occurs upon stoichiometric levels of T a  and 
PDE.
In order to understand the activation of PDE by transducin, we first must have a 
complete understanding of the behavior of the catalytic dimer (PaP) lacking the 
inhibitory y subunits. Limited trypsin proteolysis of the y subunits will be examined, but 
there is a concern that the proteolysis could alter the catalytic or regulatory properties of 
Pap (Hurley and Stryer, 1982). Thus, these results will be compared to PaP prepared 
nonenzymatically, although there are limitations to this approach since previous attempts 
have not released all o f the y (Yamazaki et al., 1990). The high affinity interaction 
between y and PaP has made it difficult to get a complete characterization o f the catalytic 
dimer Pap, as well as an accurate measurement for the binding affinity o f y for PaP 
(Yamazaki et al., 1990; Yamazaki et al., 1996b; Arshavsky et al., 1992). Indeed, there is 
some question as to whether or not y is released from mammalian PDE, or whether it is
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simply displaced from the active site o f Pap (Whalen and Bitensky, 1989; Whalen et al., 
1990).
2. Extracting y  from  cell extracts to evaluate the significance o f  post-translational
modifications o f  y
Based on sequence analysis o f y, it has been proposed that phosphorylation or ADP- 
ribosylation o f  the inhibitory y subunit may regulate the activity o f PDE in vivo. Visual 
transduction is a highly regulated process, and these reversible modifications could occur 
during times o f adaptation when the rod cell is completely saturated or exposed to a low 
level o f background light.
To address the physiological significance of post-translational modification o f the y 
subunit, we had to extract the y from purified ROS for chemical analysis. Previous 
approaches to extracting y from purified mammalian PDE or from bovine ROS 
membranes used heat, acetic acid, or a combination o f heat and formic acid to release y 
(Hurley and Stryer, 1982; Wensel and Stryer, 1986; Hayashi et al., 1991). To extract y 
from illuminated amphibian ROS homogenates, washes with GTP were done to release 
Ta-GTP in a complex with y, followed by reverse-phase HPLC to purify the y (Yamazaki 
et al., 1980; Yamazaki et al., 1983; Yamazaki et al., 1990). For the purpose of exam ining  
light-induced modification o f the y subunit, methods to extract the y directly from dark- 
adapted frog ROS had to be developed. There are many proteins that are soluble in frog 
ROS, and others that may be released under the conditions o f y extraction. Thus, it would 
be helpful to enrich for y prior to MS-fingerprinting. One common method that is used to
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further purify and concentrate proteins is to use a solid phase matrix. It is also easily 
combined with reverse-phase HPLC which can further purify the desired protein.
3. Identifying proteins which associate with PDE to form  a signaling complex
The y subunit is not the only protein believed to regulate PDE. Photoreceptor 
PDE is unique in having C-terminal isoprenyl modifications that bind it to the disk 
membranes. P a  contains a famesyl group while Pp has a geranylgeranyl group (Anant et 
al., 1992). This membrane association makes it difficult to determine proteins that bind 
to PDE. Previous research has examined the role of some key PDE-binding proteins and 
the situations under which they bind to PDE. It has been found that T a  in its non­
activated state is capable of binding to PDE, although with lower affinity (Gray-Keller et 
al., 1990; Kutuzov and Pfister, 1994). It is possible that PDE exists in a complex with 
several proteins, allowing for an accelerated response to light activation. Indeed, the 
interaction o f PDE with several proteins may be dependent on light exposure (Maftei et 
al., 2000). For example, GARP2 (glutamic acid-rich protein) is believed to bind to PDE 
during bleaching adaptation, to prevent cGMP hydrolysis when the rod cells are 
completely saturated (Korschen et al., 1999).
There are several different ways to characterize PDE binding proteins. Extraction 
o f PDE from the membranes could disrupt protein-protein interactions under some 
conditions, so a comparison o f several methods should be examined. PDE can be 
released from ROS membranes using a hypotonic buffer (Emeis et al., 1982), or with 10 
mM CHAPS detergent (Maftei, 2000). An alternate way to release PDE from the 
membrane is to incubate overnight with a 15-fold excess o f  5 protein over PDE (Norton
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and Cote, 2001). Varying the method o f extraction (hypotonic, detergent, or 5 protein) 
will help identify artifacts that might occur with any one extraction method. Alternate 
methods of PDE purification should also be examined. Immunoprecipitation, gel 
filtration, and pull-down assays can all be used for separating PDE from proteins that are 
in solution but not associated with PDE. Once proteins have been identified by protein 
staining, they can be characterized by western analysis or by mass spectroscopy.
4. Investigation o f  5  binding proteins in ROS
In mammalian retinas, -30%  of the PDE exists in a soluble form bound to a 
protein called 5 (Gillespie et al., 1989; Florio et al., 1996). It is believed that 5 binds to 
PDE at its C-terminus, releasing it from the disk membranes of the rod outer segment 
where transducin is localized, and preventing the enzyme from being activated upon light 
exposure (Cook et al., 2000; Cook et al., 2001; Norton and Cote, 2001). Recently, 
several published studies have proposed that 5 may play a general role in signal 
transduction due to its wide tissue distribution (Florio et al., 1996; Marzesco et al., 1998). 
The majority o f 6 expression is found in the retina, but its presence in the brain and 
adrenal glands suggests that the role of the 5 protein exists in all nerve cells, and not 
specifically as a regulator o f PDE in photoreceptor cells (Florio et al., 1996). The C- 
terminus o f the 5 protein encodes for a putative PDZ binding domain (Marzesco et al., 
1998) which could bind to many different proteins. PDZ-containing proteins are often 
located to microdomains on a specific plasma membrane (Marzesco et al., 1998). It was 
found that deletion of the PDZ domain of 5 destroys the membrane localization o f 8 in 
epithelial cells (Marzesco et al., 1998).
86
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Alignment o f the 5 sequence with RhoGDI, a protein involved in regulating 
membrane association o f Rho and Rab GTPases (Hoffman et al., 2000), shows 24% 
sequence identity in the known prenyl binding domain (Nancy et al., 2002). This is 
consistent with the observation of that 5 has been shown to solubilize Rab 13, a 
geranylgeranylated Ras-related protein, in addition to Pa(3 (Marzesco et al., 1998). The 
ability o f 8 to solubilize RPGR (Linari et al., 1999b) and Arl3 (Linari et al., 1999a), two 
non-prenylated proteins, could occur through the PDZ-binding domain of 8 or possibly in 
a region o f 8 that diverges significantly from RhoGDI (Marzesco et al., 1998; Nancy et 
al., 2002). The large variety of proteins that bind to 8 also suggest that 8 may play a role 
in scaffolding by allowing proteins to come together as a complex.
Chapter 4 addresses the regulation of PDE by PDE-binding proteins, with a strong 
focus on the y subunit. Several experimental results encouraged us that further analysis 
was necessary to fully understand the interaction o f y with Pa|3. First o f all, the literature 
contained no convincing measurements for the maximum catalytic activity of frog rod 
Pap  and whether the activity of transducin and trypsin activated PDE are equal. Our 
results demonstrate that one of the y subunits is not displaced from the catalytic site upon 
transducin activation o f frog PDE. Second, in pilot experiments to investigate the 
phosphorylation of y we developed a method by which in vivo levels o f Py 
phosphorylation could be measured. Third, we carried out preliminary experiments to 
identify possible regulatory interactions of PDE with other proteins using gel filtration 
chromatography. Finally, to examine the potential role o f 8 in rod photoreceptors, the 
chapter concludes with studies of 8 binding proteins that are present in ROS.
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Materials and Methods
Materials. Frogs (Rana catesbeiana) were purchased from Niles Biologicals. 
Membranes for filter binding assays were obtained from Millipore. [3H]cGMP was 
purchased from PerkinElmer Life Sciences. Immunoblotting reagents, substrates and 
nitrocellulose and PVDF membranes were purchased from Pierce or BioRad. All other 
chemicals were obtained from Sigma.
Preparation o f  purified rod outer segments (ROS). Rana catesbeiana were decapitated in 
the dark and the eyes were dissected under infrared light. The retinas were removed and 
osmotically intact ROS were purified on a discontinuous Percoll density gradient as 
previously reported (Cote, 2000). The cells were homogenized with a mortar and pestle 
at 4° (Dumke et al., 1994). Pseudointracellular medium (LIM) was used for most cell 
preparations: 77 mM KC1, 35 mM NaCl, 2.0 mM MgCl2, 1.0 mM CaCl2, 10 mM HEPES 
(pH 7.5), 2 mM dithiothreitol, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 5 pM 
leupeptin, and 1 pg/ml pepstatin. The concentration o f rhodopsin was measured by 
difference spectroscopy (Bownds et al., 1971). An alternative buffer was used when PDE 
activity measurements were done (see below). Endogenous nucleotides were eliminated 
by incubation o f the homogenized ROS in the dark for 30 minutes at room temperature. 
The amount o f PDE in the sample was determined by a cGMP binding assay (see below).
Bovine ROS from frozen retinas were purified under infrared light on a 
discontinuous sucrose gradient (McDowell, 1993). ROS were homogenized at 4° in an 
isotonic medium (25 mM Tris pH 7.5, 30 mM NaCl, 60 mM KC1, 2 mM MgCl2, 1 mM
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DTT, mammalian protease inhibitor cocktail) . The amount o f PDE was determined by 
an activity assay.
Preparation o f  recombinant y. Bovine recombinant y was expressed in Escherichia coli 
and purified as previously reported (Granovsky et al., 2000). The final purity of the y 
protein was found to be >97% by Coomassie staining on acrylamide gels. The 
concentration o f the y subunit was determined by spectroscopy and correlated with its 
ability to inhibit trypsinized PDE activity upon addition o f  2 mol y per mol PDE (Cote, 
2000). The activity assays and spectroscopy results agreed to within 10% for all o f the 
experiments in these studies.
Preparation o f  recombinant frog  GST-8. Recombinant frog 5 was prepared as described 
in the Methods section of Chapter 3. The protein was produced in E. coli as a GST- 
fixsion protein. The GST was removed from 8 using a thrombin cleavage kit, followed by 
purification on a glutathione column. The final sample was concentrated by 
ultrafiltration and stored in 50% glycerol at -20°.
PDE activity assays. The amount o f cGMP hydrolyzed by trypsinized, transducin- 
activated, and y-depleted Pap was measured by a phosphate release assay as previously 
described (Cote, 2000). The buffer used for this assay (TEM) contained: 20 mM Tris 
(pH 7.5), 10 mM MgCb, 0.5 mg/ml bovine serum albumin. The assay was done in a 96 
well plate by addition o f  10 mM cGMP to the activated PDE-containing samples. The
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measurements were taken at a time when less than 30% o f the total cGMP was 
consumed.
cGMP binding assays. PDE binds cGMP with high affinity to two noncatalytic cGMP 
binding sites. Since it is the only photoreceptor protein to bind cGMP with high affinity, 
measurements o f [3H]cGMP binding to frog PDE allow estimates o f the active PDE 
concentration (Cote, 2000). 1 pM [3H]cGMP was added to PDE preparations in the 
presence o f 200 pM zaprinast (to prevent cGMP hydrolysis) and incubated for 10 min at 
room temperature. 10 pi portions were then filtered through a pre-wet 0.45 pm 
nitrocellulose filter and washed with ice-cold pseudointracellular medium. Filters were 
shaken in scintillation fluid (Ultima Gold) for 20 minutes and radioactivity was measured 
in a Packard scintillation counter.
Gel filtration o ffrog  PDE. Purified frog ROS homogenates were pelleted by 
centrifugation (3 minutes; 110,000 gaV)- Isotonic soluble proteins were removed and the 
pellet was washed in hypotonic buffer containing 10 mM MgCl2 (Hypotonic buffer: 5 
mM Tris-HCl (pH 8), 0.5 mM ethylenediamine-tetraacetic acid, 1.0 mM dithiothreitol, 
and mammalian protease inhibitor cocktail) to remove any remaining  soluble proteins. 
The membranes were then extracted three consecutive times with hypotonic buffer 
lacking Mg2+ to release PDE from the membranes. The first extraction included a 10 
minute incubation on ice prior to pelleting the membranes. The concentration of PDE in 
the hypotonic extract was determined by cGMP binding and cGMP hydrolysis. The 
PDE-containing extract was then chromatographed on a Superdex 200 gel filtration
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column at 0.5 ml/min equilibrated in 5 mM Tris-HCl (pH 8), 0.5 mM ethylenediamine- 
tetraacetic acid, 10 mM NaCl, 1 mM DTT and mammalian protease inhibitor cocktail.
0.3 ml fractions were collected for analysis. PDE-containing fractions were determined 
by measuring cGMP hydrolysis o f a portion o f the fraction that had been exposed to 
trypsin on ice for 10 minutes. To concentrate the proteins in the fraction, the desired 
fractions were precipitated with 3.5% TCA. The TCA was added for 5 minutes at room 
temperature then centrifuged (3 min at 12,000 rpm) to pellet precipitated proteins. The 
supernatant was removed and the pellet resuspended in gel sample buffer. The samples 
were neutralized using 1 M Tris-HCl (pH 8).
Preparation o f  Pa/3. For these experiments, Pap  was made by trypsin proteolysis or by 
nonenzymatic removal o f the inhibitory y subunits. For trypsin proteolysis, a  time course 
of trypsin addition was used to determine the amount of trypsin and the length o f  time of 
proteolysis needed for each preparation (Figure 4.1). PDE was added to TEM buffer and 
incubated on ice. Trypsin was added, the sample was mixed and remained on ice 
throughout proteolysis. The trypsin proteolysis was quenched by the addition o f  soybean 
trypsin inhibitor, either by addition o f a small amount o f the PDE to the trypsin inhibitor, 
or by adding a 6-fold excess (compared to trypsin amount) to a large amount o f 
trypsinized PDE. The samples were then brought to room temperature prior to cGMP 
addition. To ensure accurate results, three time points of cGMP hydrolysis were 
measured for each o f  the trypsinized PDE samples.
For non-enzymatic preparations o f P ap , several different methods were examined 
for their ability to release y from Pap (See Results, Table 4.1). Purified, nucleotide-
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Figure 4.1. Time course o f  frog PDE trypsinization. Trypsin (50 pg/ml) was added to 
purified frog ROS (114.1 nM PDE) on ice. Trypsin activity was quenched by additing 10 
p.1 PDE into 90 p.1 o f soybean trypsin inhibitor (50 (j.g/ml). Samples were diluted with 
TEM and brought to room temperature. cGMP was added and three time points were 
taken for each o f the different trypsin proteolysis lengths. The rate values plotted 
correspond to the linear regression o f the cGMP incubation time points. V ^x  for the 
experiment was 4770 cGMP/PDE/sec ([PDEfinai] = 10.3 nM).
depleted frog ROS were exposed to light in LIM. GTPyS was added for a 1 hour 
incubation at 4° to allow y to be released from Pap . Membranes were pelleted in the 
centrifuge at 110,000 x gaV. The supernatant was discarded, and the process was repeated 
to release more y from Pap. The amount of y remaining on PDE was determined by its 
ability to bind [3H]cGMP, since the P ap  lacking y do not bind cGMP in the noncatalytic 
sites. The total concentration o f PDE in the sample was determined by measuring 
[3H]cGMP binding in the presence of a molar excess o f recombinant y.
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Purification o f y using the Sep-Pak column. The cartridge was solvated in 10 ml o f 
acetonitrile, then flushed with 10 ml o f 10 mM Tris, pH 7.5. Next, the y-containing 
sample was loaded on the cartridge and washed with 5 ml of 10 mM Tris. The y was 
eluted with 0.2 ml fractions o f the following solvents: 10 % acetonitrile/0/1% TFA, 40% 
acetonitrile/0.1% TFA, and 100% acetonitrile/0.1% TFA. This procedure was routinely 
used in the lab for purification o f y. The amount o f  y recovered from the column was 
determined by spectrophotometry (OD2 7 7) or by its ability to inhibit trypsinized PDE.
Pull-down assay o f  proteins binding to immobilized 5. To measure the binding o f ROS 
proteins to S, two similar methods were used to immobilize 5 to beads. In the first 
approach, 67 pg of GST-5 was added to 20 pi of glutathione-agarose beads. The sample 
mixed at 4° for 1.5 hours before centrifuging the beads (5 min. at 12,000 rpm). The 
beads were washed with TMN buffer (TMN buffer: 50 mM Tris pH 7.5, 0.1 M NaCl, 0.5 
mM MgCl2) prior to the addition o f ROS extracts (extracted using 10 mM CHAPS or 
hypotonic buffer). After incubating at 4°, samples were centrifuged and the supernatants 
were collected (unbound fraction). The beads were washed with TMN buffer three times 
and then the 5-binding proteins were eluted with 10 mM reduced glutathione in 10 mM 
Tris (pH 8). The samples were TCA precipitated, resuspended in Laemmli gel sample 
buffer, neutralized, and heated to 80° for 10 minutes prior to being analyzed by SDS- 
PAGE. Any proteins remaining on the beads were collected by adding Laemmli SDS- 
PAGE gel sample buffer and heating the sample to 80° for 10 minutes. The specificity o f 
protein binding to immobilized 5 protein was determined in two ways. First, ROS
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extracts were incubated with beads lacking bound 8. Second, an excess o f GST-8 was 
added to the ROS sample during the incubation to compete with the 8-beads.
A second set o f experiments utilized 8 covalently coupled to beads. 8 (cleaved 
from its fusion partner by thrombin proteolysis) was coupled to CNBr-activated beads 
following the manufacturer’s instructions. Untreated sites were blocked by incubating 
the beads with 0.1 M ethanolamine for an hour at room temperature. The beads were 
then washed and stored in 0.02% sodium azide. These beads were then used in the same 
manner as described above to pull down 8 binding proteins form ROS extracts. To 
eliminate nonspecific binding of proteins to the S-beads more completely, 0.1% Triton X- 
100 was added to the sample during incubation and to the wash buffer (wash buffer: 50 
mM Tris-HCl pH 8, 0.1% Triton X-100, 0.5 M NaCl).
For experiments testing bovine ROS extracts, bovine PDE was hypotonically 
extracted from purified ROS membranes as described above for frog PDE hypotonic 
extraction. Detergent extraction of PDE resulted from addition o f  10 mM CHAPS to 
resuspended bovine ROS membranes in isotonic buffer. This was repeated 3 times and 
the extracts from each were pooled together as one sample.
Results and Discussion
The conditions o f  trypsin proteolysis o f  y  greatly affects the maximum PDE activity. To 
better understand y binding to Pap, the catalytic dimer itself must be studied. One 
common method for preparing PaP is by trypsin proteolysis o f the enzyme (Hurley and 
Stryer, 1982). When the PDE holoenzyme (PaPyy) is exposed to trypsin, the y subunits
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are cleaved (PaP) and the C-terminus o f PDE is also cleaved, causing PDE to be released 
from the disk membrane (Oppert et al., 1991; Catty et al., 1992). The maximum rate 
measurements for trypsin-activated PDE4were found be greater than for transducin 
activation (Norton et al., 2000). There is wide variation in the literature for the kat value 
for trypsinized and transducin-activated PDE, although generally trypsin activates PDE to 
a greater extent than transducin activation (Pugh, Jr. and Lamb, 1993).
While examining trypsin proteolysis o f PDE (tPDE) as a method o f preparing 
PaP, we found that the concentration o f PDE at the time o f the trypsin proteolysis greatly 
affected the activity o f the enzyme, such that the lower the concentration of the PDE at 
the time o f  trypsinization, the higher the maximal catalytic activity. However, if the PDE 
was trypsinized at a high concentration (>100 nM PDE) and subsequently diluted prior to 
assaying the activity, an increase in maximum activity was also seen (Figure 4.2). The 
fact that the proteolysis and assay conditions alter the catalytic rate obtained may account 
for the variation seen in the literature for the maximum catalytic rate o f trypsinized frog 
PDE (Whalen and Bitensky, 1989; Whalen et al., 1990; Yamazaki et al., 1996a;
D'Amours and Cote, 1999). Interestingly, the maximum activity observed by 
trypsinization was about 7500 cGMP/PDE/sec. The maximum kat for transducin- 
activated PDE (taPDE) was found to be 4400 cGMP/PDE/sec (D'Amours and Cote,
1999; Norton et al., 2000).
These differing values for the maximal rate o f tPDE and taPDE could arise from a 
number o f different circumstances. First, it could be that transducin is only activating 
one o f the two catalytic sites on PDE. However, trypsinization o f PDE should result in a
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Figure 4.2. Dilution o f trypsinized PDE gives a higher maximum catalytic activity. Frog 
ROS homogenates (120 nM PDE) were trypsinized on ice with 0.2 mg/ml trypsin for 10 
minutes. The reaction was quenched with 1.25 mg/ml STI. The trypsinized PDE was 
diluted to the indicated concentrations. Three time points of cGMP incubation were used 
to obtain the Pap rate measurements. This graph is representative o f 2 separate 
experiments.
kcat exactly twice the kcat of taPDE, which is not the case. It is possible that transducin 
activation of PDE completely activates one catalytic site, and slightly (10-20%) activates 
the second site.
An alternate scenario could be that Ta-GTP activates each catalytic site equally, 
but not to 100%. This would result in any ratio of activation by transducin, including a 
maximal observed rate of 60% the tPDE kcat- Thus, equal activation o f each catalytic site 
agrees with the results we obtained.
Alternatively, negative cooperativity could also account for the result, if  
activation at one site makes activation o f the second site less likely. We also cannot rule 
out from our studies the presence of diverse populations of PDE (Pap, Paa, PPP). This
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scenario could provide the exact maximum rates we found, with each population 
contributing differently to the final value.
One hypothesis is that the maximum rate for trypsin-proteolyzed PDE should be 
8800 cGMP/PDE/sec, and that not all o f the y inhibition was abolished. Figure 4.1 shows 
that the PDE has been trypsinized to its maximal activity. However, it is possible that a 
fragment o f the y subunit remains after trypsin proteolysis o f PDE that would inhibit 
catalysis to some extent. Analysis of the trypsin cleavage sites (using Protein Parameters 
in EXPASY) predicts that a fragment (aa 45/46-87) containing the inhibitory C-terminus 
is formed. To test this, the different samples o f  diluted tPDE used in Figure 4.2 were 
subsequently transducin activated by addition o f  GTPyS, but no further increase in 
activity was seen. However, results presented in Chapter 3 would suggest that PDE 
released from the membrane upon trypsinization removes it from the vicinity of T a- 
GTP.
The C-terminus of y is the primary region involved in inhibition of cGMP 
catalysis. Addition o f a y antibody to the C-terminal region o f y might be expected to 
compete with PaP for y binding and subsequently activate the enzyme. However, when 
trypsinized PDE was incubated with an excess o f  C-terminal y antibody, no increase in 
tPDE activity was observed (data not shown).
Upon trypsinization, frog  PDE retains a fragment o f  ythat is not removed by dilution o f  
the sample. To examine whether there was truly a tryptic fragment (specifically 45/46- 
87) o f y that did not dissociate from Pap  upon trypsin proteolysis, we tried purifying the 
trypsinized PDE by ultrafiltration or gel filtration. Due to the results shown above
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(Figure 4.2), we suspected that the concentration o f the tPDE may alter the affinity o f the 
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Figure 4.3. Trypsinized PDE binds a fragment o f y even after gel filtration 
chromatography. Frog ROS homogenates at two different concentrations (concentrated: 
100 nM PDE, A; and diluted 2 nM PDE, B) were trypsinized to 60% of their maximum 
activity. Membranes were removed by centrifugation (3 min, 110,000 x gaV). The 
trypsinized PDE-containing supernatants were purified by gel filtration chromatography 
on Superdex 200. PDE-containing fractions were pooled and concentrated by 
ultrafiltration (Millipore Biomax 30K MWCO filter). Western analysis was done using 
the antibody to the C-terminal region o f y (UNH-9710, 1:30,000).
shows that a 4.5 kDa fragment o f y was not completely removed upon gel filtration when 
the sample was trypsinized at either a high concentration or a low PDE concentration. 
Full length y is observed at —11 kDa on SDS-PAGE. Figure 4.3 shows a loss o f  the 11 
kDa band and an appearance of a 4.5 kDa proteolytic band that co-elutes with PDE 
catalytic subunits during gel filtration chromatography. If  the y fragment had dissociated 
from PaP, then it would have eluted from the Superdex 200 in the included volume for 
this column (—25 ml), not at an apparent MW o f300,000 kDa. The fragment was also 
observed bound to tPDE when treated with two consecutive dilutions followed by
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ultrafiltration prior to gel filtration (data not shown). This method was used to increase 
the likelihood that the low MW fragment would separate from Pa(3 and enter the filtrate, 
while PaP would remain in the retentate. The co-purification o f PaP with the 4.5 kDa y 
fragment under these conditions suggests that the fragment o f the y subunit remains 
associated with PaP upon trypsinization, even at low PDE concentrations. Thus, this 
fragment could be limiting the maximum activity o f the trypsinized PDE. Dilution of the 
sample to sub-nanomolar PDE concentrations may induce dissociation o f the 4.5 kDa 
fragment, thereby further increasing the apparent kcat.
Developing alternative methods to prepare Paf3 lacking y. It is possible that the 
higher catalytic activity of trypsinized PDE compared to transducin activated PDE could 
arise from a proteolytic artifact resulting from cleaving a portion o f Pap. Therefore, we 
searched for an alternative method to remove the y subunits from the PDE holoenzyme. 
Upon transducin activation, Ta-GTP binds to y and releases some o f it from its 
association with PaP (Yamazaki et al., 1990). Yamazaki et al. (Yamazaki et al., 1996b) 
found that the release o f y from Pap with Ta-GTP was higher in the presence o f salt. 
Unfortunately, none o f the conditions we tested were able to remove all o f the y from 
Pap. We found that the best method for preparing Pap was to centrifuge nucleotide- 
depleted frog ROS homogenates after two consecutive one-hour incubations in the 
presence o f either GTPyS or GTP (Table 4.1). To compare the catalytic activity of this y- 
depleted PaP to that o f trypsinized PDE, we determined the amount of y remaining on the 
PaP using a cGMP binding assay (see Methods). PaP lacking y subunits cannot bind 
cGMP with high affinity to the noncatalytic cGMP binding sites
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Table 4.1
Summary of PaP preparations
Concentration 
of NaCl
pH GTPyS Number of 
spins
Amount of y 
remaining (mol 
y per mol PDE)
200mM NaCl 7.5 GTPyS = 2 x [rho] 2 0.25
300 mM NaCl 7.5 0 1 0.25
600 mM NaCl 7.5 0 1 0.24
300 mM NaCl 8.5 0 1 0.25
600 mM NaCl 8.5 0 1 0.27
300 mM NaCl 9.5 0 1 0.33
600 mM NaCl 9.5 0 1 0.35
600 mM NaCl 6.5 0 5 0.26
0 7.5 GTPyS = 2 x [rho] 3 0.16
Table 4.1. Nonenzymatic preparation of P aP . ROS homogenates were treated 
with varying levels o f salt, pH and GTPyS to remove the y subunit of PDE. The y was 
removed by centrifugation for 3 min (110,000 gaV). The amount o f y remaining was 
determined using a cGMP binding assay. Filter binding was done on the Pap sample 
with and without recombinant y to indirectly estimate the amount of y bound to the 
depleted PaP samples.
(Arshavsky et al., 1992; Cote et al., 1994). Thus, the amount o f cGMP binding to y- 
depleted PaP represents a 1:1 relationship with the amount o f y remaining bound to Pap. 
By comparing this value with the binding of the same PDE sample supplemented with 
excess recombinant y, the amount of endogenous y still bound to PaP can be determined.
We then measured the maximal activity of the PaP preparation and extrapolated 
the value to determine the catalytic rate we would obtain i f  no y was bound. By this 
method, the kcat for PaP was estimated to be 7000 ±180 cGMP/PDE/sec. The similarity 
of this result to the kcat obtained with trypsinized PDE demonstrates that trypsin 
proteolysis o f PDE does not alter significantly the maximum catalytic activity o f the PaP
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dimer. Also it supports the hypothesis that transducin-activated PDE only activates PDE 
to 50%-60% o f the maximum possible rate, most likely by activating primarily 1 active 
site.
The fact that not all o f the y could be removed from the catalytic dimer suggests 
that not all PaP molecules are behaving identically. PDE heterogeneity is also suggested 
by the observation that only 60%-70% o f the total frog PDE can be released from the disk 
membrane by hypotonic extraction. In an effort to discover whether the tight association 
of y to PaP is related to the tight membrane association o f PDE, we hypotonically 
extracted our y-depleted PaP sample. We found that there was no direct correlation 
between membrane association and y association of PDE. Measurements o f the PaP 
released from the disk membranes by hypotonic extraction showed that the released PDE 
still contained the same ratio o f y to PaP as was seen prior to extraction (data not shown).
These observations were used as a basis for examining the activation o f frog PDE 
by transducin, focusing specifically on the role o f the y subunit. The results o f this 
detailed investigation are presented in Chapter 3 o f this thesis.
The y subunit o f PDE can be extracted from  purified, intact frog  ROS fo r  analysis ofpost- 
translational modifications. The tight association between PaP and y heightens the need 
for understanding how this interaction is regulated in vivo. It has been suggested that 
phosphorylation o f y plays a role in adaptation of the cell by increasing or decreasing the 
affinity o f y for either PaP or T a  (Hayashi et al., 1991; Udovichenko et al., 1993; Xu et 
al., 1998; Tsuboi et al., 1994; Matsuura et al., 2000; Hayashi et al., 2000). To examine 
the occurrence o f post-translational modifications of the y subunit in vivo, we developed a
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Figure 4.4. Extraction of endogenous y from frog ROS. Frog ROS homogenates (0.2 
nmol o f  rhodopsin) were treated to remove soluble proteins. The ROS membrane pellets 
were treated in the following ways: TEM+ (A), TEM+ boiled for 5 min (B), 10% 
acetonitrile/0.1% TFA (C), 10% acetonitrile/0.1% TFA heated to 75° for 5 min. (D), 20% 
acetonitrile/0.1% TFA (E), 20% acetonitrile/0.1% TFA heated to 75° for 5 min (F), 30% 
acetonitrile/0.1% TFA (G), and 30% acetonitrile/0.1% TFA heated to 75° for 5 min (H). 
The samples were spun in the Airfuge at 30 psi for 5 minutes as soon as possible. 
Supernatants were collected and the pellets were resuspended in TEM+. The results were 
analyzed by western analysis using the C-terminal y antibody.
method for quantitating and partially purifying y from ROS extracts. Several conditions 
were tested and it was found that heating the sample for 5 minutes at 75° in 30% 
acetonitrile/0.1% TFA released all o f the y from ROS homogenates (Figure 4.4). For 
samples where we wanted to extract y from intact ROS, we obtained better recovery of 
endogenous y if  the whole cells were first treated with acetonitrile, then sonicated or 
disrupted by a freeze-thaw cycle prior to heating to 75°.
After extraction, the y was purified on a solid reverse phase C-l 8 Sep Pak 
cartridge in order to avoid loading large amounts of impurities from frog ROS extracts on 
an HPLC column (see Methods). This method was first optimized using purified 
recombinant y. Figure 4.5 shows the elution profile o f the recombinant y measured by 
absorbance ( O D 2 7 7 )  as a function o f the acetonitrile concentration. Elution o f y from the
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Figure 4.5. Purification o f recombinant y on reverse phase Sep Pak cartridges. 27 
pg o f recombinant bovine y was loaded on the Sep Pak cartridge (WAT023501) 
equilibrated in 10 mM Tris, pH 7.5. The sample was washed with 10 mM Tris. The 
sample was then eluted with 0.1 ml of each of the following buffers: 10% 
acetonitrile/0.1% TFA (fractions 1-5), 20% acetonitrile/0.1% TFA (fractions 6-9), 30% 
acetonitrile/0.1% TFA (fractions 10-13), 40% acetonitrile/0.1% TFA (fractions 14-17), 
and 50% acetonitrile/0.1 % TFA (fractions 18-22). The elution of y was measured by 
absorbance (OD277), as well as by the ability of the y to inhibit trypsinized PDE(not 
shown).
Sep Pak cartridge occurred at 40% acetonitrile/0.1% TFA. Fraction 14 showing the 
highest absorbance at 277 nm also had the greatest inhibitory potency for trypsinized 
PDE. The amount recovered was 67% (18 pg) o f the y protein loaded on the column (27 
Pg)-
Once this simple enrichment procedure for y was developed, ROS samples could 
be tested under different illumination conditions to examine whether changes in y 
phosphorylation serve as a regulatory mechanism o f visual transduction. These initial
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experiments were the basis for work performed by Michael Paglia in the lab (Paglia et al., 
2002).
Identifying novel PDE binding proteins. The y subunit is only one protein that binds to 
PDE. Other proteins that are known to interact with PDE are transducin, GARP2 and 5. 
However, understanding the role o f each o f these PDE-binding proteins, and when they 
each may bind in vivo has not been well established. It is also likely that there are some 
yet unidentified proteins that bind to PDE in vivo, possibly contributing to the regulation 
of visual transduction. We chose to analyze PDE solubilized from ROS membranes 
using gel filtration chromatography.
Nonactivated PDE from frog ROS was hypotonically extracted from washed ROS 
membranes. This extracted frog PDE was applied to a Superdex 200 gel filtration 
chromatography column, and the PDE-containing fractions were identified by a cGMP 
hydrolysis assay (Figure 4.6A). As seen in panel B o f  Figure 4.6, the PDE-containing 
fractions have other protein bands besides P a  and Pp. Proteins of lower molecular 
weight that elute in these fractions must be in a protein complex or form oligomers.
Bands o f particular interest are those that appear solely in the fractions containing the 
majority o f the PDE activity (fractions 30 and 31). A doublet arises at about 50 kDa 
which is not seen on the gel prior to fraction 30. Other protein bands that could be 
important are -74 , 65, 55, and 43 kDa. However, just because they elute at the same 
molecular weight as PDE does not mean that they are bound to PDE, as they could be in 
a completely different protein complex, or in association with another protein that
104
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.




































MW HS 2 7 2 8  29 30 31 32 33 34 35 36 37
Figure 4.6. Gel filtration of hypotonically extracted proteins from frog ROS membranes. 
9 pmol of hypotonically extracted frog PDE was run at 0.5 ml/min on a Superdex 200 gel 
filtration column. 0.3 ml fractions were collected. A PDE activity assay was done to 
measure the elution profile o f PDE from the column (panel A). The top axis shows the 
corresponding molecular weight standards. The fractions were TCA precipitated, 
suspended in gel sample buffer, and then run on a 12% SDS-PAGE gel and stained with 
Coomassie (panel B). The starting material (HS; 1 pmol PDE) was included on the gel to 
show the total proteins run over the column.
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binds to PDE. Thus, by this method alone, it is difficult to discern what proteins are 
bound to PDE. However, comparisons of this method with others such as 
immunoprecipitation o f PDE, and western analysis of known ROS proteins would allow 
for the identification o f some of the proteins on the Coomassie-stained gel. Although y is 
associated with PaP during gel filtration chromatography, it cannot be detected under 
these conditions.
These results show preliminary evidence for novel PDE binding proteins. 
Releasing PDE from its membrane-associated state may retain some of the protein 
interactions that exist on the disk membrane. One hypothesis is that there is a complex o f 
visual transduction proteins that associate to allow for the rapid response time o f visual 
excitation. A protein complex may also facilitate regulation o f visual transduction during 
bleaching and light adaptation. The PDE signaling complex may mirror the Drosophila 
invertebrate phototransduction system, where a PDZ-containing InaD protein organizes 
phototransduction components on the rhabdomeric membrane (Tsunoda et al., 1997; 
Bahner et al., 2000; Tsunoda et al., 2001).
Several ROS proteins in addition to PDE bind to 8 in vitro. Chapter 3 of this thesis 
presents a detailed study o f the 5 protein in frog ROS. This project evolved from 
previously published work done with bovine photoreceptor cells (Florio et al., 1996;
Cook et al., 2000; Cook et al., 2001) and from our interest in proteins binding to PDE.
The hypothesis that 6 may be involved in membrane binding o f numerous proteins in a 
variety of cells led us to examine the possibility that there are other proteins in ROS that
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could be associating with this protein. Many proteins involved in signal transduction use 
prenylation as a means to reduce signaling pathways to a 2-dimensional process by 
binding the important proteins to membranes. The putative PDZ and prenyl binding 
domains o f the 5 protein suggests a scaffolding role for 5 that brings various proteins 
closer to one another in the cell. Figure 4.7 examines solubilized proteins from purified 
frog ROS that can be precipitated by GST-5 bound to glutathione beads. For each o f  the
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Figure 4.7. 5 binding proteins from various ROS extracts. A. Frog ROS homogenates 
(19 pmol PDE) were incubated overnight with recombinant frog GST-5 (0.4 nmol 5). 
The sample was centrifuged at 30 psi for 3 min in the Airfuge. GST-5 released PDE (6 
pmol PDE) was incubated with 20 pi o f glutathione agarose beads for 1 hour at 4°. B. 
and C.Hypotonically extracted PDE (H, 4 pmol) or CHAPS extracted PDE (C, 5 pmol) 
were incubated with 20 pi o f glutathione-agarose beads with 1.5 nmol GST-5 bound for
1.5 hour at 4°. The samples from all three extractions were centrifuged 5 min at 12,000 
rpm to remove unbound proteins in the supernatant (U). The beads were then washed 
with 50 pi of TMN buffer (W). Proteins that bound to the beads were eluted (P) with 10 
mM reduced glutathione in 10 mM Tris (pH 8). The glutathione beads were heated in 
Laemmli sample buffer to 80° to remove any residual proteins that were not released by 
glutathione treatment (B).
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extraction methods, a portion of the PDE exists bound to the GST-5 beads. A few other 
bands could be bound to PDE or 5 in this experiment, such as the band at 60 kDa in the 
hypotonic and CHAPS extracted samples. In the sample where the ROS membranes 
were incubated with GST-5 overnight, two very interesting bands are bound to the beads 
at — 50 and 48 kDa. These are possibly proteins binding directly to 5 as they are not 
found in the samples extracted with CHAPS or hypotonic buffer. This experiment has 
several limitations that control the amount o f information we can obtain. One problem 
consistently observed is the breakdown o f the GST from the GST-5. Thus any bands on 
the Coomassie gel that are less than 43 kDa could be from GST-5 breakdown in the 
sample, and not ROS proteins bound to the beads. Second, the interaction o f GST-5 with 
the glutathione beads is not very strong, so a portion o f GST-5 is found in the unbound 
samples and the remainder is eluted from the beads and found in the precipitated sample 
on the Coomassie gel. Thus, if  there are any proteins running around 43 kDa they would 
be overshadowed by the GST-5 that is in the sample.
To overcome these limitations o f doing pull-down with glutathione-agarose, we 
coupled purified bovine 5 to CNBr-activated Sepharose (See Methods). Figure 4.8 
presents 5 binding proteins found in bovine ROS. For this experiment, three different 
samples were incubated overnight with 5-beads. PDE is found to bind to 5 as expected.
It was verified by western analysis that PDE and y both exist bound to the 5-beads (data 
not shown). The hypotonically extracted proteins show the highest number of proteins 
precipitated with the 5-beads. Proteins at 50 kDa, 48 kDa, 40 kDa, and 10 kDa are 
specifically bound to the 5-beads. It is important to note that the precipitated proteins
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may be directly binding to 5, or bound to protein that is itself bound to 8 (such as PDE). 
Although CHAPS removed more o f the proteins from the membrane, the CHAPS 
extracted sample shows less proteins precipitating with 8, possibly due to disruption of 
protein-protein interactions by the detergent.
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Figure 4.8. 8 binding proteins in bovine ROS extracts. Isotonic soluble proteins (0.59 
pmol PDE), hypotonically extracted proteins (8.25 pmol PDE), and CHAPS extracted 
proteins (11.3 pmol PDE) were incubated with 30 pi o f 5-beads overnight at 4° in the 
presence o f 0.1% Triton X-100. The unfractionated sample (S) is shown for each 
condition. Nonspecific binding was estimated by the addition o f 0.9 nmol bovine GST-5 
to each sample prior to the incubation (8). The beads were precipitated by centrifugation 
(5 min at 12,000 rpm). Unbound proteins were collected (U). The samples were washed 
3 times with 50 pi o f  wash buffer (see Methods). Proteins were eluted from the beads by 
heating to 80° in 2* Laemmli sample buffer (B).
An important reason for examining the proteins other than PDE that are co- 
precipitating with 8 is the low level of 5 in ROS compared to that of PDE. Quantitative 
analysis o f  the 8 protein (presented in Chapter 3), shows that there is a large excess of 
PDE in the outer segment compared to 8. This suggests that PDE may not be the major
109
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
target o f 8 in the outer segment o f  the photoreceptor cell. It would be very difficult for 8 
to regulate PDE at such low quantities. The other proteins that are pulled down with the 
8 protein would be more likely to be the candidate for 8 action in vivo as they may exist 
in similar quantities.
Some o f the protein bands stained here could be the same as those observed 
bound to PDE after gel filtration chromatography (Figure 4.7). Specifically, both the 8- 
precipitation reaction and the gel filtration showed several bands in the 37-50 kDa range 
on the Coomassie gel. T a  and TP are known to run in this range, and it would not be 
unexpected to find some T a  bound to PDE, as some Ta-GDP can bind to PDE, though 
with a lower affinity than Ta-GTP (Gray-Keller et al., 1990; Kutuzov and Pfister, 1994). 
At the same time the Ty subunit is bound to the photoreceptor cell disk membranes by a 
famesyl group similar to Pa. Previously published result suggest that Ty and Tp would 
not be precipitated, as they are not released from the disk membranes with 8 (Cook et al., 
2001).
There is still work that needs to be done to identify the proteins binding to PDE or 
the 8 protein in vivo. Western analysis of the gel filtration and 8-precipitation samples 
with antibodies to known ROS proteins will give more information about some o f the 
protein bands found on the Coomassie gels. Other proteins can be purified from the 
SDS-PAGE and sequenced by MS-fingerprinting. These results can be compared to 
experiments that examine 8 binding proteins in retinal extracts. There may be a common 
protein that has yet to be identified that serves as the primary 8 target in several cell 
types.
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Conclusions
The results presented in this chapter represent pilot studies for future projects 
related to rod PDE regulation by novel proteins, as well as preliminary experiments that 
formed the foundation for the published work presented in Chapters 2 and 3.
The inability to extract all of the PDE from ROS membranes, along with the 
incomplete removal o f  y from PDE by non-enzymatic methods both suggest a 
heterogeneity in the PDE population in rod outer segments. Heterogeneity with respect 
to post-translational modification of the y subunit was one avenue that was partially 
explored in this chapter in our efforts to develop methods to enrich for y from complex 
protein extracts o f rod outer segments. It is possible that a a  or pp homodimers may exist 
in addition to the a p  catalytic dimer that is assumed to predominate, serving as a sub­
population o f PDE that with different y-binding or membrane-binding properties. The 
observation that the kcat o f activated PDE was not significantly different when catalytic 
dimers were prepared by trypsin proteolysis o f the y subunit versus extraction o f y by 
transducin activation and centrifugal fractionation demonstrated that the proteolytic 
treatment did not create artificially high catalytic rates for cGMP hydrolysis.
The role o f the 17 kDa 5 protein remains unclear. The preliminary work in this 
chapter provides a new approach to identifying proteins that bind to 6 in photoreceptor 
cells. This is an important first step to understand the role 5 plays to potentially organize 
proteins that bind to 5 in photoreceptor cells. The strategy o f immobilizing potential 
PDE binding proteins to identify novel proteins that interact with PDE and its known 
associated proteins may lead to characterization o f a multi-protein signaling complex on 
the disk membrane where PDE is activated, inactivated and allosterically regulated.
I l l
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SUMMARY
The research presented here examined the regulation o f rod photoreceptor PDE 
upon transducin activation. In order to observe the mechanisms o f PDE regulation, we 
first had to characterize the basic properties of transducin activation. We found that 
transducin activation o f frog rod PDE reached half the maximal activation rate of the 
catalytic dimer (PaP), prepared by trypsin proteolysis or by a nonenzymatic method of y 
extraction. The y subunit plays an important part in regulating visual excitation by 
inhibiting PDE activity. The interaction o f y with PaP is correlated with cGMP binding 
to the noncatalytic sites o f  PaP, such that when cGMP is bound, y is more tightly 
associated. Indeed, we found that the release of cGMP from the noncatalytic cGMP 
binding sites directly correlates with y release from Pap.
A result that we continually observed in our studies o f PDE regulation was a 
heterogeneity in protein and ligand binding to PDE. First, upon transducin activation of 
PDE, there was heterogeneity in the dissociation of cGMP from the noncatalytic binding 
sites. The effect o f transducin activation at the noncatalytic sites could be overcome by 
the addition of excess y. However, heterogeneity also existed in the binding o f y to PaP, 
as two distinct classes o f y binding sites were seen when titrating PaP with y in the 
presence o f cGMP.
When transducin activation o f PDE is prolonged, such as during light adaptation, 
additional regulatory mechanisms are believed to take place. One protein hypothesized 
to be involved in PDE regulation during light adaptation is the 17 kDa 8 protein. We
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examined the role o f the 8 protein in regulating frog PDE. Biochemical experiments on 
the effect o f 5 on frog PDE agreed with previously published results done on m ammalian 
PDE, showing 5 releasing PDE from the membrane and decreasing the maximal 
transducin activated rate o f PDE. However, quantitative analysis resulted in less than 0.1 
mol 5 per mol PDE in frog and bovine retinas localized to ROS. Consistent with this 
finding, increased purification of ROS showed a decrease in the amount o f 8 compared to 
the entire retina. This suggests that 8 binding to rod PDE may be an artifact resulting 
from 8 entering the outer segment during the purification process. Previous 
immunocytochemical experiments were done with a 8 antibody that was not shown to 
identify the 17 kDa 8 protein on immunoblots. Due to the low levels o f 8 measured in 
outer segments by immunoblot analysis, we chose to reexamine 8 localization in the 
retina by immunocytochemistry. Preliminary evidence observed with the 8 antibody that 
we developed resulted in localization of 8 to several cells in the retina, but not to rod 
outer segments.
These results suggest that the designation of the 8 protein as a subunit o f PDE was 
premature. Recently published work on RhoGDI (Nancy et al., 2002) suggests that 8 
may be one o f a family o f proteins that is involved in the trafficking o f prenylated 
proteins to distinct membranes, due to the sequence similarity of 8 and RhoGDI. The 
small amount o f 8 in the rod outer segment suggests that PDE is not the central target for
8. Preliminary experiments using immobilized 8 protein show that several different 
proteins in the rod outer segment are capable of binding to 8, or alternatively, form a
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complex with a protein that does bind to 5. One hypothesized role for the 5 protein could 
be to form a scaffold for a group on interacting proteins.
The highly specialized role o f photoreceptor cells presents a unique model system 
where the majority o f  the protein and membrane components are involved in the same 
process. Numerous interactions o f the proteins in the rod outer segment are likely to 
work in concert to regulate visual transduction. Understanding the details o f  how the 
visual transduction pathway is regulated will allow us to determine the cause o f diseases 
leading to the loss o f vision. Using this information, drugs can be developed to combat 
vision loss in patients suffering from these diseases, allowing them to maintain a more 
independent and fulfilling life.
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